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OXYGEN TOXICITY: 
The frequency with which oxygen is used in clinical medicine must not blind us to the 
fact that it has many clinical toxic effects. Oxygen supplied at a concentration greater 
than those in normal air has long been known to damage plants, animals and aerobic 
bacteria such as E. Coli (Balentine, 1982). Although molecular oxygen contains an even 
number of electron, it has two unpaired electrons in its molecular orbital with the same 
quantum number (Pietrangelo, 1996). Therefore, when accepting a pair of electron from 
a molecule, new electrons must be of parallel spin to fit in the vacant space of the 
orbital This imposes one electron transfer reaction at a time. These reactions may lead 
to the generation of reactive oxygen species (ROS). Indeed, there is considerable 
evidence that even 21% oxygen has slowly manifested the damaging effect (Halliwell 
and Gutteridge, 1984). The effect observed vary considerably with the type of organism 
used, its age, physiological state and diet, such as presence of varying amounts of 
vitamins A, E, and C, transition metals, antioxidants and polyunsaturated fatty acids in 
the diet (Halliwell and Gutteridge, 1984 ). The effect of these ROS remaui low as 
specific enzymes exist to remove them from the biological system. 
Perhaps the earliest suggestiontoejq)lain oxygen toxicity was the inhibition of cellular 
en2yme by oxygen. However, the rate of enzyme inactivation by oxygen in aerobic cells 
are too slow and too limited in extent, to account for the rate at which toxic effect 
developed and many enzymes were totally unaffected with oxygen. This led Gershman 
and Gilbert (1954) to propose that many of the damaging effect of oxygen could be 
attributed to the formation of oxygen radicals (Gilbert, 1981). This hypothesis was 
developed by Fridovich (1975,1978, 1983) into a theory of superoxide production in 
vivo which plays a major role in the toxic effect of oxygen. 
REACTIVE OXYGEN SPECIES IN BIOLOGICAL SYSTEM: 
The observation that oxygen enhances the generation of free radicals implies that some 
sort of redox cyclic with oxygen acting as an electron acceptor, takes place (Reszka et 
al., 1996). It was observed that radical formation is strongly dependent on the presence 
of oxygen. Strong electron paramagnetic resonance (EPR) signals form 5,5-
dimethylpyrroline-N-oxide (DMPO) adducts were observed only in aerated samples 
where as, in air-free solutions the EPR signals were weaker or were virtually absent 
(Reszka et al., 1996). 
It is now accepted that free radicals, especially active oxygen-centered radicals such as 
superoxide radical, singlet oxygen, hydroxyl radical, alkoxyl and peroxyl radical which 
are highly heterogeneous attack lipids, proteins and DNA to induce membrane damage, 
protein modification, enzyme inactivation, strand break and base modification of DNA, 
eventually leading to a variety of pathological events such as cancer and aging (Sies, 
1991), atherosclerosis, diabetes mellitus, inflammation (Abella et al, 1996), lung 
diseases (Iwamae et al, 1998 ), AIDS (Pace et aL, 1995, Edeas et aL, 1995) and 
cardiovascular pathologies (Hogg and Kalyanaraman, 1998). 
Numerous studies have attempted to correlate the deficit of protective system against 
radicals to several pathologies associated with the abnormal production of ROS 
(Schwartz et al., 1991, Cillery et al., 1989). However, these investigations were always 
made difficult because of the large number of protective systems, their possible 
biological interference and above all, analytical difficulties (Abella et aL, 1996). To 
overcome these problems several authors have developed different methods to measure 
the antiradical potential of the organism (Abella et al., 1996). Although, oxygen is 
essential for living organisms the formation of ROS is seen to be common place in 
aerobically metabolizing cells. For instance, the interaction of these ROS with cellular 
components forms the basis for the pathophysiology ofseveral disease states. While 
ROS are considered to be potentially toxic to many cellular components, this toxicity is 
also employed by organisms to kill invading bacteria and parasites (McCord and 
Fridovich, 1978). ROS are often generated as a byproduct of biological reactions such as 
electron transport in mitochondria or formed due to exogenous fectors like cigarette 
smoke, polluted air or radioactive gases (Cerutti, 1991), Free radicals mediate a number 
of significant cellular processes, including apoptosis and cancer (Okuno etaL, 1998). 
Also it is generally suspected that free radicals could be the mediator of the effect of 
temperature osmolarity and nutrient levels onthe cells (Nagarathnammaetal, 1997). 
Free radicals are also important in plant defense mechanisms against invading 
microorganisms (Chamnongpol et aL, 1995) which are also expected to play a 
significant role in determining bioreactor productivity (Rao and Sureshkumar, 2001). 
SOURCE AND SIGNIFICANCE OF FREE RADICALS IN BIOLOGICAL 
SYSTEM: 
The primary source of free radical in most oxygenated biological system is the 
superoxide radical, which is in equilibrium with its protonated form, the hydroperoxide 
radical. The major sources of these free radicals are modest leakage from the electron 
transport chain of mitochondria, chloroplasts and endoplasmic reticulum. Although 
superoxide radical is relatively unreactive in comparison with many other radicals. In 
biological system, it can be converted to other more damaging radicals like peroxyl, 
alkoxyl and hydroxyl radical (Dean et al., 1997). 
When neutrophils are activated, a series of metabolic activities are stimulated (Hatherill 
et al., 1991) collectively these changes are termed as respiratory burst. The respiratory 
burst is associated with increase oxygen uptake, NADPH production from hexose 
monophosphate shunt and reduction of oxygen forming superoxide radical and hydrogen 
peroxide. The majority of oxygen consumed by leukocytes is converted into superoxide 
radical or other reactive oxygen products (Babior, 1978). Molecular oxygen taken up by 
the leukocytes is univalently reduced to water. 
The intermediate products, superoxide radical, hydroxyl radical and hydrogen peroxide 
of this pathway are reactive in biological systems to varying degree. The formation of 
the superoxide radical results from a membrane-bound NADPH oxidase during 
respiratory burst when granulocytes or macrophages are activated to particular stimuli 
(Tsou and Yang, 1996). Due to the activation of the membrane-bound NADPH oxidase, 
electrons are transferred from cytosolic NADPH to extra cellular oxygen producing the 
superoxide radical From this one-electron-reduced form of oxygen, other ROS such as 
hydrogen peroxide, singlet oxygen, and hydroxyl radical are formed from subsequent 
reactions, partly catalyzed by metal ions (Wang et al., 1993). These ROS are essential 
for killing microorganism and also play a majdt role in inflammation (Chaves et al., 
1996, Zhao et al., 1998) or in reperfusion injury (Omar etal., 1991). Since NADPH 
oxidase is a surface bound enzyme, a proportion of superoxide radical diffuses into the 
extracellular space. Molecules of superoxide radical are capable of forming hydrogen 
peroxide and oxygen by dismutation reaction. Howe%er, the spontaneous rate of 
dismutation is very slow in biological system (McCord. 1974). Superoxide dismutase 
(SOD) catalyses the reaction and is deemed responsible for the majority of hydrogen 
peroxide evolved by the leukocytes (Klebanoff, 1980). This hydroxyl radical is 
postulated to be formed from the modified modified metal-catalyzed Haber-Weiss or 
Fenton reaction where a transition metal serves as a reducing agent. (Klebanoff, 1980). 
02+Fe^^ • 02 + Fe^^ 
Fe""^  + H2O2 • Fe'^ + 0K + OR 
The formation of the toxic oxygen-derived free radicals by leukocytes is important for 
defense against infection. The ability of leukocytes to produce superoxide radical is 
necessary for destroying some type of bacteria. Free radicals are not solely accidents of 
aerobic metabolism. Superoxide radical is generally deliberately produced by activated 
macrophages and some other immune system cell as a cytotoxic weapon (Babior, 1987). 
Mammalian macrophages can also generate another free radical, nitric oxide, which 
contribute significantly to the killing of bacteria and tumor cells (Hibbs et al., 1988). 
Nitric oxide can combine with superoxide radical to produce another potent damaging 
agent peroxynitrite, which is as reactive as hydroxyl radical (Beckman et al., 1990). 
Since nitric oxide is also produced for intracellular signaling by various other cell types 
(Knowles and Moncada, 1992), peroxynitrite might be a common biological agent for 
radical damage. 
The physiological role of free radicals have become a prominent area of interest in 
antioxidant-prooxidants research (Minghetti and Levi, 1998, Mohanakumar et al., 1998). 
Many of the chemical agents that induce cell killing by apoptosis also stimulate the 
intracellular generation of ROS (Burkitt et al., 1996). Also the production of ROS is an 
important mechanism whereby neutrophils mediates their antibacterial activity (Catz et 
al., 1995). 
The killing of many bacterial strains by neutrophils is greatly decreased under anaerobic 
conditions (Halliwell and Gutteridge, 1985). Chronic granulomatous disease is 
associated with the inability of phagocytic cells to exhibit the respiratory burst (Babior, 
1978). Indeed, patients suffering from chronic granulomatous diseases, an inherited 
condition in which phagocytosis is normal but the respiratory burst is absent show 
persistent and multiple infections especially in the skin, lungs, liver and bones by those 
bacterial strains whose killing by neutrophils require oxygen. 
Activated neutrophils, macrophages and other cells release superoxide radical not only 
mto phagocyte vacuole but also into their surrounding tissue fluids where it can give rise 
to hydrogen peroxide and hydroxyl radical. Hydrogen peroxide vapor possibly 
originated from alveolar macrophages has been detected in human breath (Halliwell and 
Gutteridge, 1985). Release of these products can help phagocyte to attack opsonized 
foreign cells such as cancer cells and parasitic worms. Released oxygen radicals can kill 
the phagocytes themselves probably by inducing damage to the plasma membrane. 
Neutrophils contain SOD enzymes but that cannot offer protection against externally 
generated superoxide radical. Neutrophils also contain catalase, glutathione peroxidase 
activities, together with reduced glutathione, which can help to protect against hydrogen 
peroxide. 
COPPER ENHANCES THE GENERATION OF REACTIVE OXYGEN 
SPECIES: 
The adult human body contains about 80 mg of copper (Halliwell and Gutteridge, 1984). 
Copper is absorbed in the intestine and transported by albumin to the liver. After hepatic 
uptake, copper can be incorporated mto copper-containing enzymes or into 
ceruloplasmin, which can then be transported into the blood (Britton, 1996). Copper in 
the cytoplasm is predominantly bound to metallothionin, and any excess copper is 
excreted in the bile mainly through a lysosome-to-bile pathway (Britton, 1996). The 
copper complex enter the blood and most of the copper bind tightly to serum albumin 
which is in equilibrium with a small 'pool' of copper complexes (Halliwell and 
Gutteridge, 1984). In the liver the copper is taken up and incorporated into the 
glycoprotein ceruloplasmin which is then released into circulation. About 95% of total 
plasma copper is found in this protein, the rest being attached to albumin or amino acids 
(Harrison and Hoare, 1980). Cells must take up and degrade ceruloplasmin in order to 
obtain copper from it (Gutteridge, 1981). 
Hepatic copper accumulation results from the reduction in the biliary excretion of 
copper, as seen m patients with Wilson disease, biliary obstructions or cholestisis 
(Stemlieb, 1994). Transition metal ions especially copper and iron ions frequently have 
unpaired electrons, thus are excellent catalyst and play a decisive role in the generation 
of strong reactive species from the less reactive ones for instance, by catalyzing the 
formation of hydroxyl radical from hydrogen peroxide (Pietrangelo, 1996). Fortius 
reason, cells usually keep metal ions very firmly bound to protein (Halliwell and 
Gutteridge, 1986). The most prominent reactions involved in this metal catalyzed 
hydroxyl radical generation are: 
0-2 + M ^ ° • O2 + M "•' 
H2O2 + M "•' ^ OH- + OH • + M "^ 
Net: 0-2 + H202 ^ OH + OH +02 
The overall reaction is often referred to as the modified metal-catalyzed Haber-Weiss 
reaction. This has been most often studied with iron salts but copper ions will also 
catalyze the reaction, in fact cuprous sahs generate hydroxyl radical from hydrogen 
peroxide faster than ferrous salts (Halliwell and Gutteridge, 1984), 
Is free copper ion available to make hydroxyl radical from hydrogen peroxide? Addition 
of Cu(l) salts to a system generating hydrogen peroxide in vitro causes formation of free 
hydroxyl radical, but this is prevented by histidine or albumin at physiological 
concentrations (Rowley and Halliwell 1983). Hence the copper ions in blood serum 
cannot give rise to free hydroxyl radical. Similarly, the protein concentration within the 
cell is very high and if any free copper ions are available they should rapidly become 
protein-bound and unable to catalyze the formation of free hydroxyl radical (Halliwell 
and Gutteridge, 1984). By contrasts, albumin does not prevent Fe(Il)-dependent 
formation of free hydroxyl radical. It may, however, be that the bound copper ions can 
still generate hydroxyl radical which reacts immediately with the binding molecule and 
thus cannot be detected in free solutions as suggested by Samuni et al. (1981). Not only 
do metals reflects physiological factors that can influence the protein structure, but 
transition metals are especially essential tor the survival of organisms by participating in 
various biologically hnportant redox reactions (Paik et al., 1999). 
Unabsorbed dietary iron may increase free radical production in the colon to a level that 
could cause mucosal cell damage or increased production of carcmogen (Lund etal., 
1999). The epidemiological evidence supporting a link between colorectal cancer and 
diet is strong (Willet et al., 1999). A prospective study showed that liigh iron 
consumption is associated with an increased risk of colorectal cancer (Wurzemann et al., 
1996). Higher concentrations of plasma iron were associated with distal tumors, but a 
high dietary intake independent of red meat consumption, was significantly associated 
with an increased risk of cancer of the proximal colon (Lund et al., 1999). 
AZroE RADICAL FORMATION AND POSSIBLE IMPLICATIONS: 
Catalytic oxidation of sodium azide produces the azide radical and results in its addition 
to the 6-meso position of the prosthetic group (DePillis and Montellano, 1989). Azide 
radical was used as a model of one-electron rapid oxidant (Jovanovic et al., 1995). 
Horseradish peroxidase in the presence of sodium azide and hydrogen peroxide mediates 
the one-electron oxidation of azide ions, forming azide radical (Montellano et al., 1988), 
and it has been suggested that azide radical reacts with molecular oxygen to form nitric 
oxide (Montellano et al., 1988, Kalyanaraman et al., 1985). The oxidation rate of 
hypotaurine by superoxide radical was increased in the presence ofsodium azide in 
contrast with the expected inhibition (Pecci et al., 1999). Azide radical produced by the 
oxidation of azide anion by the horseradish peroxidase, hydrogen peroxide system 
stunulated the oxidation of the added taurine (Pecci etal., 1999). It is concluded that 
azide anion competes with hypotaurine for superoxide radical generating the azide 
radical which transfer the radical to hypotaurine. It is knovra that azide anion reacts with 
superoxide radical with high rate constant (Vile and Tyrrel., 1995). 
Azide radical is a strong one-electron oxidant able to oxidize thiols and other sulfiir 
compounds, phenols and other products (Zhao et al., 1994, Devasagayan et al., 1991). In 
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a basic aqueous solution the azide radical is found to oxidize aromatic compounds such 
as anilline and phenoxide ions and their derivatives (Alfassi and SchuUer, 1985). 
Compounds like benzene, toluene and anisole are not observably oxidized by azide 
radical. Azide radical can be readily prepared radiolytically by hydroxyl radical by the 
oxidation of azide anion. Bemg a neutral radical which does not absorbs significantly 
above 300 nm it is very promising as a selective oxidant for pulse radio lysis studies. 
Several investigators have used azide radical as an oxidant in radiation chemical 
research of interest to inorganic (Eriksen et al., 1981) and radiobiological system (Land 
et al., 1983,Butler et al., 1984). This azide radical is readily formed either by flash 
photolysis (Treinin and Hayon, 1969) or pulse radiolysis(Hayon and Simic, 1970) of 
aqueous sodium azide solution and has a very narrow absorption band at 274 nm and 
little absorption above 300 nm. This low absorption provides an important advantage in 
optical pulse radiolysis studies since it readily allows measurement on many transients 
in a spectral region. As a result one can directly examine the production of oxidized 
product and can study details of the oxidation process even while the initial radical is 
present. Another advantage of azide radical is the non-ionic character where as, most of 
the more commonly used secondary oxidants are ionic. Effects of charge and 
dependence on ionic strength are thus, not involved. While the hydroxyl radical is also 
neutral, it frequently reacts simuhaneously via several competing pathways like 
extraction of atom, addition to double bond or to an aromatic ring, or by electron transfer 
so that a number of intermediates may be initially present. In contrast azide radical 
appear to react prunarily via electron transfer simplifying the secondary chemistry 
(Alfassi and Schuller, 1985). Because azide radical reacts primarily by electron transfer 
it is also expected to be much more selective in its reaction than hydroxyl radical. 
RIBOFLAVIN GENOTOXICITY: 
Riboflavin (Vitamin B2), with recommended daily requirement of approximately 2-3 
mg, is widely distributed in human tissue and fluids in free and conjugated forms 
(Spector, 1960). Riboflavin is chemically 6,7 dimethyl-9-D-l ribityl-iso-alloxazine 
(Fig. 1). Riboflavin has been found widespread application in food products both as a 
Fig. 1. Structure of riboflavin. 
CHpOH 
— C - O H 
H - N 
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nutrient and as a coloring agent (Counsell, 1981) and as a fortificant in bread 
preparations (Srivastava, 1986)-
Unlike many other food colorants, riboflavin was commanded unquestioned favor from 
regulatory agencies all over the world (Fao, 1981), since earlier toxicological studies 
have failed to reveal any delel^ erious effects (Haveland 1981). As a coenzyme, riboflavin 
is responsible for the growth ^ d development of foetus and the maintenance of mucosal 
epithelial and eye tissues (Lozinova, 1986). It is used as a supplement inpatients 
suffering from various riboflavin deficiency diseases. Riboflavin is a yellow pigment 
that can be reversibly reduced by accepting or loosing a pair of hydrogen atom (Frati et 
al., 1997). Flavins can be incorporated into enzymes either covalently or noncovalently. 
In either case the flavins ar^ never a substrate but always a true coenzyme and remains 
tightly bound to the protein during reactions. The prosthetic groups of these enzymes are 
riboflavin, flavin mononucleotide, and flavin adenine dinucleotide (Zheng and Omstein, 
1996). 
However, evidence obtained by many mvestigators has indicated that riboflavin in the 
presence of oxygen and visible light is lethal to animal and human cells in culture and 
induces mutations in micro-oi^ ganisms (Pathak, 1988) and is cytotoxic to eukaryotic cells 
(Misra, 1990). Riboflavin is also considered as a potential chromophore for inducing 
genetic damage from miJltivitamin formulations exposed during illumination 
phototherapy (Ennever, 19^3). Riboflavin is known to possess photosensitization 
characteristic (Lozinova, 19^6). Photosensitized riboflavin is known to decompose to 
lumichrome and lummiflaviil (Smith, 1963). These photodegradation products are also 
photoreactive (Joshi, 1989). There is definite evidence to support that photosensitized 
riboflavm generates ROS via oxygen dependent photodynamic action (Joshi, 1985). 
However, a number of photosensitizing properties of riboflavin are reported which raise 
concern due to their lethal effects on biological systems (Smitli, 1963). It is known that 
EDTA, RNA, DNA, enzymes and n:iany other compoimds are photooxidized in flavin 
sensitized reactions (Taylor, 1^71). 
Riboflavin is ubiquitous in human tissues, when exposed to UV radiation of sunlight, 
riboflavm induces photodaniage of the skin (Minamietal., 1999). Sometimes human 
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skin receive less oxygen from arterial blood than other tissues, such as under oxygen 
damaging conditions. The more human undergo physical conditions requiring oxygen, 
such as hard jogging under strong sunlight, the more photoinduced damage occurs in the 
skm (Minami et al,, 1999). 
Irradiation of riboflavin produces superoxide radical, singlet oxygen, and the riboflavin 
radical (Kumari et al., 1996, Kim et al., 1993). These radicals have short half-life time 
and weak reactivity that they are not fully accepted as collective attacking agents 
(Minami et al., 1999). It has been demonstrated that irradiation of riboflavin produces 
substantial amount of hydrogen peroxide (Sato et al, 1995) which has long half-life and 
penetrates cell membrane freely. When transition metals react with hydrogen peroxide, 
they produce deleterious ROS, hydroxyl radical (Henle and Linn, 1997, McCormick et 
al., 1998), which is a well-known strong oxidant (McCormick et al., 1998) and is 
generated from hydrogen peroxide by the modified metal-catalyzed Haber-Weiss 
reaction. 
Kumari et al. (1996) presented data showing the production of superoxide radical and 
hydroxyl radical during the photosensitized oxidation of riboflavin using tetramethyl 
piperidone as a spm-trapping agent. Riboflavin has complex photochemistry both in the 
presence and absence of other substrates (Kim et al., 1993). 
Amongst the many sensitizers available, riboflavin is of special importance because of 
its widespread occurrence as colored pigment (Britton, 1983) and as an integral 
component of flavm coenzymes (Zubay, 1989). Because of its presence in ocular tissue, 
riboflavin induced conformational changes in the microenvironment of thiol groups have 
received considerable attention (Bose et al., 1986). 
It has also been shown that riboflavin upon ejqjosure to visible light in the presence of 
oxygen exerts its toxic effects and causes injuries leading to cell death (Bradley and 
Sharkey, 1977). It has been suggested that the production of superoxide radical by 
energy transfer from photoexcited riboflavin to molecular oxygen largely attributes to 
phototoxic effect (Korycka-Dahl and Richardson, 1980). Certain drugs and chemicals 
with photosensitizing capabilities could cause cytotoxic effect by damaging the cell 
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membranes (Ali et al, 1991). It has also been pointed out that the inhibition of cellular 
enzymes is mediated by a free radical mechanism as a consequence of the formation of 
lipid peroxides in the intracellular membrane (Inaba et al, 1982). 
In view of the relevance of riboflavin m physiological processes and its ability to 
produce ROS upon photoexcitation, it is considered to be a suitable model to investigate 
the possible mechanism of photooxidation of biological entities (Tsia et al., 1985). 
PHOTODYNAMIC THERAPY: 
Photodynamic therapy involved the treatment of diseased tissues and cells using a 
photosensitizer and visible light. Such photomedical treatment have been used since the 
ancient Egyptian time but it was only in 1993 that this therapeutic modality was made 
available to modem medicine with the approval of photofrin for the treatment of bladder 
cancer in Canada (Dolphin, 1994). 
Photodynamic therapy is based on the attractive basic concept of combining two 
therapeutic agents, harmless by themselves, to obtain selective tumor destruction 
(Hoebeke et al., 1997). Evidences are accumulating that the generation of ROS is 
intimately associated with the photodynamic effect of many sensitizers involved in 
cancer therapy. A highly activated sensitizer can transfer energy from its triplet state by 
two processes, directly to molecular oxygen with the generation of superoxide radical or 
by interaction with solvent or substrate by electron or photon transfer with the 
generation of radicals (Hoebeke et al., 1997). 
Certain organic compounds of low molecular weight designated as photosensitizers, can 
damage biomolecules upon irradiation with light (Burgstaller et al., 1997). Endogenous 
photosensitizer products may lead to misreplication, mutations and cancer (Shibutani et 
al., 1991). Natural and synthetic photosensitizers have attracted considerable interest 
because of their utilization in photochemotherapy, the treatment of disease with 
photosensitizing drug plus light (Diwu and Lown, 1994). 
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HUMAN RED BLOOD CELLS: 
The mammalians RBC afford a simple experimentally accessible and useful whole cell 
and membrane system for the study of many biological processes. It originates from the 
bone marrow as nucleated precursor that losses all the organelles and several 
cytoplasmic proteins during maturation through an intricate process of differentiation. In 
the absence of these, the mammalian RBC rely mainly on plasma membrane for its 
shape (Lux, 1979). The human RBC membrane is the best studied membrane system 
m view of its ready availability and ease of isolation. It is unusually durable, surviving 
thousands of passages through circulation during its 120 day life span. The basis for the 
resilience of the cell is the mechanical properties of the plasma membrane, since the 
usual cytoplasmic structural proteins and organelles are lost during differentiation 
(Bennet, 1985). 
Human RBC membrane is a composite of two structural units viz. membrane 
cytoskeleton and membrane bilayer which are responsible for maintaining the shape and 
structural integrity of the mature RBC (Elgsaeter et al., 1986). While the membrane 
bilayer is composed of lipids and integral membrane proteins, the cytoskeleton is a 
reticulate type of structure formed from three major proteins (spectrm, actin and 
polypeptide 4,1) and several minor peripheral proteins, which are associated with 
cytoplasmic face of the membrane bilayer through protein-protein as well as protein-
phospho lipid interactions (Bennet, 1985). The plasma membrane of the RBC behaves 
like a semisolid with elastic properties which are not restricted by intracellular 
cytoskeletal network of protein but are mostly attributed to the matrix of membrane 
proteins (Kirkpatrick, 1976). The network of peripheral proteins of the cytoskeleton 
controls cell shape and provides the mechanical strength necessary to prevent rupture of 
the cell by the high shear forces experienced in blood capillaries (Clague and Cherry, 
1989). The membrane bilayer skeletal association controls the lateral mobility of the 
integral membrane proteins (Sheetz, 1983) and is also considered a major fector in 
maintaining the asymmetric phospholipids distribution across the RBC membrane 
bilayer (Haest, 1982). 
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Extensive literature is available on the nature and function of the principal polypeptides 
of human RBC membrane (Juliano, 1973, Haest, 1982, Bennett, 1985). Only a brief 
account of the available information on these polypeptides is therefore, presented: 
Spectrm (Bands 1 and 2): The spectrin network in combination with other proteins 
comprises the RBC skeleton, which seems to maintain the mechanical stability of the 
membrane to control cell shape and deformability. (Marches!, 1979, Mohandas et al, 
1983). The spectrin molecule is very flexible and contains two antiparallel, non-identical 
subunits that are interwisted and appear as 100 imi long and 2.5 rmi wide rods in electron 
microscopy (Shotton et al., 1979). The rotational diffusion studies by Learmonthetal. 
(1989) showed the spectrin behaves neither as rigid rod nor as a compact globular 
protein. In addition to axial rotation of ribbon like spectrin molecule, faster motions such 
as mtermolecular bending and torsion distortions are also observed suggesting internal 
flexibility of the spectrin dimer. The thiol groups of spectrin were considered to be 
involved in maintaining membrane resistance to thermal damage and in controlling self 
association of dimers (Streichman et al., 1988). 
Band 3: It is an intrinsic and most abundant protein (Mr 95,000) of the RBC membrane 
(Fairbanks et al., 1971). The complete amino acid sequence of human anion transport 
protein has been deduced from cDNA(Taimeretal., 1988). In native meinbrane only 
15% of total band 3 monomer is associated with ankyrin (2.1, 2.2, 2.3) (Bennet, 1979). 
Ueno et al. (1987) have suggested that a dynamic exchange offree band 3 for ankyrin 
linked band 3 may occur in intact RBC and this may contribute to the shape change of 
RBC. 
Band 4.1: The band 4.1 of Mr 78,000 is a globular molecule of 6 nm diameter (Tyler et 
al., 1979). It participates in the interaction ofspectrin with actin (Cohen, 1983, Bennet, 
1985,Wolfe et al., 1980). It anchors the skeleton to membrane via its association with 
glycophorin (Anderson and Lovrien, 1984), band 3 (Pastemack et al., 1985) and lipids 
(Cohen etal., 1988). 
Actin (Band 5): Band 5 polypeptide (Mr 43,000) is also a component of membrane 
skeleton and forms short oligomers contaming about 10 molecules in filamentous form 
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(Brenner and Kom, 1980). Each spectrin tetramer has two actin binding sites at the free 
end. This polypeptide has been shown to play a major role in shape change of RBC. 
Band 6: This is the monomer of glyceraldehyde-3-phosphate dehydrogenase. It is a 
tetramer of Mr 35,000 subunits which binds to spectrin-actin complex and to band 3 
(Yeltman and Harris, 1980, Murthy et al., 1981). The bmding of band 6 to the 
cytoplasmic domain of human RBC glucose transport protein was studied by Lachaal et 
al. (1990). The study suggests that a significant portion of the enzyme may exist in 
association with the glucose transporter in vivo. 
In addition to these polypeptides, there are number of glycoproteins embedded in the 
lipid bilayer of RBC membrane. They comprise approximately 10% of the total 
membrane proteins. Glycophorin A is the major glycoprotein of RBC membrane. 
Red Blood Cell Lipid Composition and Organization: 
Studies on RBC lipid bilayer have been quite extensively reviewed (Stephen et al, 1972, 
Op den Kamp, 1979). The lipid bilayer is in liquid crystalline state and highly 
anisotrophic. The lipid composition of RBC is rather complex due to the occurrence of 
several variants both in the polar and non-polar moieties of the molecule and appears to 
be highly conserved (Kuypers et al, 1984). This conservation serves to mamtain the 
specific membrane properties such as permeability and resistance against mechanical 
and osmotic stress. The amount of total lipid in lO'" cells is about 5 mg and 
approximately lO' lipid molecules have been reported in the plasma membrane of a 
single red blood cell, 30% of which comprises neutral lipids, 60% phospholipids and 5-
10% glyco lipids (Copper, 1969). Cholesterol, the major constituent of the neutral lipids 
appears to be relatively randomly distributed in the bilayer (Hioggins et al,, 1973). 
Freeze fracture studies however, indicate that outer layer may contain more cholesterol 
than the inner layer of the bilayer (Fischer, 1975). 
The various phospholipids present in the RBC membrane belong to any of the three 
classes namely phosphotides, phosphoinositides and plasmalogens also called ether 
lipids. The commonly occurring phospholipids in the human plasma membrane are 
phosphatidylcholine, phosphatidylserine, phosphatidylethanolamine and sphingomyelin 
(Copper, 1969) and they constitute 32.06%, 13.54%, 30.28% and 22.15% respectively. 
A modification in RBC lipid composition has however been reported with aging by 
Prisco et al. (1991). There was a significant increase in cholesterol and total 
phospholipid content with aging where as no difference was observed in 
cholesterol/phospholipid molar ratio of RBC. 
A human RBC survive in the circulation for nearly 120 days, after which it is removed 
by the narrow splenic sinusoid or the reticuloendothelial system (Jain, 1988). During the 
life span of RBC, its membrane undergoes changes in lipid and protein content, enzyme 
activity, ion permeability, size and deformability (Clark and Shohet, 1985). 
The determination of spontaneous chemiluminescence is known to be a useful non-
invasive means for studying oxidative damage in biological systems (Miyazawa et al., 
1983). However, the chemiluminescence from living tissues is usually too weak to be 
detected and identified, because biological system has complex structure and contains 
many substances serving as radical scavengers (Yasuda et al, 1989). In light of the 
above, the oxidation of RBC membranes induced by oxidative agents serves as a good 
model for the study of oxidative damage to biomembranes. The chemiluminescence 
observed during the oxidation of RBC membrane was associated mainly with the 
peroxidation of lipids and only to a minor extent with the oxidation of proteins (Yasuda 
et al, 1989) damage to hemoglobin and hemolysis (Miki et al, 1987). 
RBC membrane represents a simple form of cell membrane whose structure and 
function has been well established. Another striking feature ofRBC that enabled us to 
use it as a model for studying the photosensitized riboflavin mediated oxidative damage 
of membrane was due to the feet that exposizre of cells to activated oxygen is an 
inevitable consequence of aerobic existence. Furthermore, the spontaneous generations 
of superoxide radical, hydrogen peroxide and hydroxyl radical have been reported m 
RBC (Inaba et al., 1982). It could be possible that a variety of free radicals including 
those originated from biological entities like lipids and proteins were formed during 
photosensitization and the combined effect is responsible to cause the membrane 
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damage (Ali et al, 1991). It is suggested that the membrane damage in terms of its 
active constituent is responsible to maintain the structure and function of the membrane 
i.e. the inhibition of membrane bound enzymes and formation of lipid peroxides (Ali et 
al., 1991). Peroxidative damage to RBC membrane and lipids may have significant role 
in the inhibition of ATPase and other enzymes. 
Peroxidation of biomembranes is accepted to be a process by which tissues are damaged 
during ischemia, inflammation and aging (Donato, 1981). Therefore, peroxidation and 
hemolysis of RBC induced by various agents have been extensively studied as a model 
for damage in RBC. This phenomenon has been suggested to play a role in irreversible 
damage during cell aging (Etlinger and Goldberg, 1977). 
It was shown that peroxyl radical attacks RBC, induce the chain oxidation of membrane 
lipid and protems and eventually cause hemolysis (Miki et al., 1987). These damages of 
RBC were inhibited by exogenous antioxidants such as ascorbic acid, uric acid, cysteine 
and glutathione (Niki, 1987). 
The participation of oxygen radical species in hemolytic states has been suggested for 
sometimes (Babior, 1981, Jacob, 1958). RBC lysis may be the end result of minor 
defects in the RBC membrane. The structural integrity of the membrane is an unportant 
feature for its resistance to peroxidative attacks (Gratzer, 1981). RBC are also 
susceptible to oxidative stress due to unsaturated membrane phospholipids (Gain and 
Shohet, 1981), continued exposure to high oxygen tension and a plethora of transition 
metals capable of serving as redox agents (Chiu et al., 1976, Pryor, 1976). The presence 
of hemoglobm and other lematin compounds may also augment the process of lipid 
peroxidation (Tappel, 1953). When an oxidizing stress overwhelms the reduction 
process of the RBC, a defect may ultimately result in hemolysis due to mability of RBC 
to resynthesize damaged components (Chiu et al., 1976). The destruction of RBC is 
postulated to occur by either membrane oxidation or hemoglobin denaturation (Hatherill, 
1991). 
During oxidative injury, the RBC membrane is stripped of phosphotidylethanolamine 
before the cell begins to hemoly^p. Phpsphotidylethanolamine contain a significant 
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amount of polyunsaturated fatty acids, which are susceptible to lipid peroxidation. 
Phosphotidylethanolamine can be regenerated by transfer offatty acid from a neutral 
lipid pool through phosphotidylcholine (Lubin and Desforges, 1972). However, 
peroxidation destroys the fatty acids ofphosphotidylethanolamine at a faster rate than 
that of transfer and hemolysis still occurs. The degradation ofphosphotidylethanolamine 
may also alter the structural relationship of the integral membrane protein spectrm, and 
result in hemolysis (Haest et al., 1977). 
Peroxidation injury may directly alter sulfhydryl groups of spectrin by forming disulfide 
bridge (Haest et al., 1977). In addition, there is evidence that altered hemoglobin become 
attached to the inner layer of the red cell membrane via disulfide linkage (Jacob, 1970). 
Malondialdehyde (MDA) formed after peroxidation of membrane lipids is capable of 
cross-linking free amino groups in the membrane. These linkages promote membrane 
rigidity and increase the splenic entrapment of RBC (Lubin and Desforges, 1972). 
Hemoglobin alterations may be reflected in globulin chain amino acid substitution. The 
substitution may change the physical and chemical properties of the heme pocket such 
that its iron can facilitate the formation of oxygen radicals. 
Furthermore, RBC membrane bound enzyme such as Na^ /K^ ATPase is affected by 
carbonyl containing substances liberated from oxidized phospholipids (Kesner et al., 
1979). The inhibition of Na*/K^ ATPase may also be related to degradation of 
phosphotidyl serine, which is associated with this enzyme. Inhibition of Na^ /K^ ATPase 
will result in increased osmotic fragility (Zheng and Omstein, 1996). 
Goldstein and Balchum (1967) demonstrated that exposure of RBC to ozone resulted in 
increased osmotic fragility associated v^ rith production of MDA. It was also 
demonstrated that hydrogen peroxide stimulate replacement of membrane fatty acids, 
with isotopically labeled fatty acids. In addition hydrogen peroxide can react with 
human RBC causing cross-linking of spectrin to hemoglobin (Snyder, 1971). During 
oxidizing conditions the presence of SOD, catalase and other radical scavengers can 
provide protection against cell lysis. 
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Red Blood Cell Antioxidant Systems: 
The RBC under physiological condition is contmuously exposed to oxidants such as the 
superoxide radical (Suzuki et al, 1984). These radicals are also produced under 
experimental conditions and/or during clinical use of some oxidizing drugs such as 
phenylhydrazine and primaquine, mhaled gases, aromatic xenobiotics, radiation and 
activated neutrophils. Mammalian RBC are particularly susceptible to oxidative damage 
because (i) being an oxygen carrier, it is exposed uninterruptedly to high oxygen tension, 
(ii) it has no capacity to repair its damaged components and (iii) the hemoglobin is 
susceptible to autooxidation and its membrane components to lipid peroxidation. 
However, the RBC have protective mechanisms against oxidative damage. 
Three main enzymes, glutathione peroxidase, catalase and SOD are known to protect the 
RBC agamst such damage. Another enzyme glutathione reductase is of importance in 
maintaining an adequate level of reduced glutathione. Two more enzymes of pentose 
phosphate pathway i.e. glucose-6-phosphate dehydrogenase and 6-phosophogluconate 
dehydrogenase also assist in protection by providing the NADPH required by 
glutathione reductase to convert oxidized glutathione to reduced glutathione (Suzuki et 
al, 1984). 
The membrane bound glutathione peroxidase (Hill and Thomally, 1983) plays an 
important role in the elimination of hydrogen peroxide under physiological conditions 
(Kurata et al., 1993). It requires reduced glutathione as a cofactor for the breakdown of 
hydrogen peroxide. There is a wide variation in Glutathione peroxidase activity in 
mammalian RBC (Kurian and Iyer, 1977, Maral et al., 1977, Agar an(J Suzuki, 1982, 
Siizuki et al., 1984). Catalase which also catalyzes the dissemination of hydrogen 
peroxide, has been reported to play a minor role as compared to glutathione peroxidase 
under physiological conditions (Cohon and Hochstein, 1963). Only at higher 
concentrations of hydrogen peroxide, the decomposition of hydrogen peroxide by 
catalase becomes prominent. 
In living cells free radicals are produced continuously increasing oxidative stress, which 
in turn, may induce tissue damage (Priy^fjarsini, 1997). Antioxidants protect the cell 
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membranes against autooxidation (Buettner, 1993). Physiological antioxidants are one of 
the major defense mechanisms in fighting against free radical induced, mediated and 
promoted disorders (Jovanovic et al., 1995). Furthermore, aging and cardiovascular 
diseases have a free radical con^onent (Bendisch, 1990, Davies, 1991, Rice-Evans and 
Diplock 1993). The proper function of the immune system appears to be dependent on 
the level of dietary antioxidants (Greenspan, 1993, Standstorm, 1994, Screck, 1991). 
While mildly beneficial in the treatment of various pathological conditions, the most 
significant role of antioxidant protections is believed to be its role m disease prevention 
(Jovanovic et aL, 1995). With increasing environmental challenges, efficient prevention 
of damage requires maintenance of the highest possible levels of defense agents 
(Jovanovic et aL, 1995). Antioxidant vitamins represents the most studied component of 
the overall antioxidant defense system which include all available antioxidants ranging 
from various nutrient suchaspolyphenols(Jovanovic,etal., 1994) to metabolites such 
as uric acid (Simic and Jovanovic, 1989) and hydroxy tryptophan (Jovanovic, et al., 
1990). 
Vitamin C, being water soluble is an excellent antioxidant in plasma, while lipid soluble 
vitamin E is effective in cell membrane (Knight et al., 1993). Therefore, the oral 
supplementation vvdth vitamins as free radical scavengers may further improve the 
longevity and viability of stored RBC. 
Failure to observe beneficial effects of antioxidant vitamin supplementation in severely 
challenged individuals have resulted in the under estimation of the significance of 
antioxidants (Heinonen and Albanes, 1994). The importance of an individual antioxidant 
in averting a particular pathological condition would depend on its availability at a site 
of oxidative challenge and its reactivity with damaging free radical oxidants (Jovanovic 
etal., 1995). 
It is quite evident that enzymatic antioxidant defense mechanisms are destroyed in RBC 
from patients with chronic renal failure because of various reasons, the consequence of 
which is more exposure to oxidative attacks, membrane lipid peroxidation, hemolysis 
and at last anemia (Durak et al., 1994). It may be possible to propose that some 
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antioxidant substances such as vitamin E or A may give usefiil results in RBC hemolysis 
observed in patient with chronic renal failure. 
The presence of SOD and catalase in human skin is well recognized and these enzymes 
provide a natural protection to the skin to minimize the harmful effects of singlet oxygen 
and superoxide radical induced by solar radiation (Pathak et al., 1987). The 
photoinactivation of SOD will increase the harmful effects of superoxide radical and 
hydroxyl radical and contribute to the increased cross-linkiug of collagen and eventually 
to the photoaging of the skin (Carbonare et al., 1992). 
DNA MODIFICATION STUDIES: 
It is generally accepted that a high proportion of human cancers is attributed to 
environmental £^ents, mainly chemical pollutants. The distribution of potential 
carcinogens in the environment is essentially ubiquitous. The human diet contains a 
variety of naturally occurring mutagens and carcinogens (Ames, 1983). The 
predominance of certain foods in some countries has been related to the hicidence of 
certain type of cancers in their populations. Therefore, dietary mutagens have attracted 
considerable interest in the past decade and a number ofstudies on dietary practices in 
relation to cancer have been undertaken. These studies suggest that a greater intake of 
fiber rich cereals, vegetables, fruit and lower consumption of fet rich products and 
alcohol would be advisable (Doll and Peto, 1981, Peto and Schneiderman, 1981). 
Although quite a large number of dietary components have been evaluated in microbial 
and animal test systems, there is still a lack of definitive evidence about their 
carcinogenicity and mechanism of actioa A majority of chemical carcinogens are 
known to form covalent adducts with DNA which is a critical target in chemically 
induced cancers (Miller, 1987, O'Connor, 1981). In order to understand carcinogenesis 
at the molecular level it is essential to determine the conformational changes in the 
target macromolecules and relate these findings to possible aberrations in the 
functioning of modified macromolecules. Of late, there has also been increasing interest 
in oxygen radicals and lipid peroxidation as a source of DNA damage and therefore, as 
promoters of cancer (Harman, 1981, Gensler and Bernstein, 1981, Totter, 1980, Tappel, 
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1980). In addition mammalian systems have evolved many defense mechanisms as 
protection against mutagens and carcinogens. The most important mechanisms may be 
those relating to oxygen radicals and lipid peroxidation. 
Considerable interest has arisen m recent years in the formation of free radicals and the 
consequences of oxidative damage to DNA. This interest derived in large part from the 
realization that the use of oxygen by aerobic organisms is accompanied by the formation 
of reactive by-products: free radical forms of oxygen that can damage most cellular 
component. Many toxic agents also generate intracellular oxygen radicals. Oxidative 
damage refers to the damage formed by these ROS. Repair enzymes that mediate the 
removal of oxidative damages from DNA help counteract the potential cytotoxic, 
mutagenic and carcinogenic effects of these damages (Demple and Harrison, 1994). 
The load of oxidative damage from endogenous process is evidently significant. As a 
measure of this load, specific oxidative damages may accumulate with time in the DNA 
of animal cells (Ames et al., 1993), although the precise numbers are subject to debate 
(Lindahl et al., 1993). Numerous inverse correlation have been made between the 
metabolic rate of various mammalian species and their maximum life span (Gutler, 
1991) and used along with other observations to argue that oxidative damage is a cause 
of aging and age-related diseases such as cancer and atherosclerosis (Sies, 1991). 
Nearly 100 different free radical damages have been identified (Dizdaroglu, 1992). Free 
radical damage to DNA constitutes a constant and significant threat for aerobic 
organisms, enzymes that attack specific oxidative damages are wide spread among 
oxygen usmg bacteria, and among mammalian cells. Although free radical attack 
produces a multitude of DNA damage, the ability of at least some of these repair 
activities to recognize a range ofsubstrates allow relatively few enzymes to repair the 
bulk of base and sugar lesions, general repair mechanisms act as secondary repair 
pathways and can handle more complex lesions (Demple and Harrison, 1994), 
Any substance that reacts with DNA is potentially carcinogenic. Exposure of DNA to 
superoxide radical generating systems cause extensive strand breakage and degradation 
of deoxyribose (Brawn and Fridovich, 1981), probably due to formation of hydroxyl 
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radical. Oxygen radicals have been suggested to be involved in the action of a number of 
DNA damaging drags (Lown et al., 1982). 
PROTEIN MODIFICATION STUDIES: 
Oxidative modification of total proteins has been described under many pathological 
conditions (Kwon et al., 1998). Proteins may thus be critical targets of ROS because 
they are present mside and outside the cell in high concentrations and since many are 
catalytic in nature modifications by free radicals may have an amplified effect on their 
activity i.e. susceptibility to proteolysis, inactivation and degradation etc. 
The modification of amino acid residues by hydroxyl radical and superoxide radical and 
subsequent changes in en2yme activity have been used to identify residues cracial for 
protein function such as methionine, tryptophan, histidine and sulfhydryl groups 
(Garrison, 1968). Enhancement in the inactivation of certain enzymes by secondary 
radicals, such as peroxy radicals has been described (Gee etal., 1985). In general, the 
consequence of radical modification of enzymes is inactivation. Of late, it has been 
speculated that repair mechanisms may exist for several of the protein modifications 
(Willson, 1983). Cellular reductants and antioxidants may replenish electron or 
hydrogen atom 'holes' after hydroxyl radical attack and cleave protein-disulfides (Wolff 
etal., 1986). 
Using BSA and Chinese-hamster ovary cell soluble proteins. Wo Iff and Dean (1986) 
have demonstrated the sensitivity of proteins to oxygen free radicals derived from y 
irradiation, metal ions and hydrogen peroxide. Oxygen free radicals derived from 
ascorbate and Cu(II) (Marx and Chevion, 1986) as well as glucose in presence of oxygen 
and Cu(II) also caused similar effects (Hunt et al., 1988). The latter reaction is important 
in the sense that it appears to contribute, in addition to Amadori rearrangement, to the 
glycation of proteins during diabetes and aging (Himt et al., 1988). 
Dean et al. (1989) have proposed that proline and histidine may be the major sites of 
damage during radical attack upon proteins, and they are transformed respectively to 
glutamate and aspartate. This was investigated using proteins biosynthetically labeled 
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with radioactive proline or histidine as targets. Free radicals were generated by copper 
and hydrogen peroxide or by y-radiolysis. Protein bound histidine was substantially 
converted to aspartate. Much proline was modified during radical attack, but it was not 
converted into glutamate. Thus, histidine and proline are unportant sites of protein attack 
by radicals and protein cleavage may result from these reactions (Dean et al, 1989). 
Davies (1987) has reported that proteins, which have been exposed to certain oxygen 
radicals, exhibit altered primary, secondary and tertiary, structure and can undergo 
spontaneous fragmentation or mcreased proteolytic susceptibility. Similarly, previous 
studies (Davies and Delsignore, 1987, Davies, 1985, Levine, 1983, Chin etal., 1982) 
have shown that oxygen radicals and other activated oxygen species such as hydrogen 
peroxide can increase protein degradation in intact cells and mtracellular organelles as 
well as in vitro systems. ROS may thus play an important role in cellular protein 
turnover. The available data indicate that active oxygen species may act by altering cell 
proteins and making them more susceptible to degradation by intracellular proteolytic 
systems (Davies, 1986, Davies, 1987, Stadnvan, 1986, Wolff et al., 1986). 
Protein Degradation As An Index Of Oxidative Stress: 
Oxygen radicals and other activated oxygen species are known to participate in 
numerous physiological and pathological processes. Situations, which augment oxidant 
exposure, or compromise antioxidant capacity, are commonly referred to as oxidative 
stress. Oxidative stress can result from exogenous sources i.e. redox-active xenobiotics 
(Davies and Doroshow, 1986, Doroshow and Davies, 1986,Marcilatetal., 1989)or 
from increased in endogenous oxidative metabolism i.e. mitochondrial electron transport 
chain (Davies et al., 1982). Oxidative stress as already mentioned, is the most ubiquitous 
stress to which mammalian cells are subjected (Sies, 1991). The mechanism of 
triggering of the stress response is under active discussion both in general stress (Straus 
et al, 1987, Morimoto et al., 1990) and as a consequence of oxidative stress (Tartaglia et 
al., 1991, Morimoto et al., 1990). The damage brought about by oxidative stress is 
expected to be exacerbated if the antioxidant enzymes themselves are damaged and 
inactivated by such events (Tabatabaie and Floyd, 1984). 
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Free radicals such as hydroxyl radical and possibly alkoxy can fragment and cross-link 
proteins (Wolff et al., 1986, Schuessler and Schillin, 1984). In the absence of molecular 
oxygen hydroxyl radical induced cross-links in proteins, which are often resistant to 
reduction, such as dityrosine (Halliwell and Gutteridge, 1984). Some cross-linking may 
also occur in the presence of oxygen but fragmentation is much more pronounced. 
Proteins are fragmented and modified by hydrogen peroxide in the presence of transition 
metals (Gutteridge and Wilkins, 1983, Wolff and Dean, 1987). Hydroxyl radical so 
generated may react with the chelating species rather than escape from the site of their 
generation. Thus, generation ofhydroxylradicalbycopper/histidinly complexes seems 
to lead to oxidation of the histidine residues to yield aspartate (Copper, et aL, 1985). 
Susceptibility Of Radical Damaged Proteins To Enzymatic Proteolysis: 
Even limited oxidative modification of certain proteins can render them more 
susceptible to enzymatic hydrolysis by a number of proteinases (Fligiel et al., 1984, 
Davies, 1987, Wolff and Dean, 1986). It has been suggested vdth respect to enzymes 
that inactivation precedes proteolysis (Hemmings, 1980, Holzer and Heinrich, 1980, 
Holzer, 1983). The degradation of other proteins may also occur by a two-step 
mechanism in which the protein is first modified such that it becomes more susceptible 
to proteolytic attack (Levine et aL, 1981, Toyo-Oka, 1982, Lev et aL, 1994). In the 
second step, a protease specific for the modified enzyme catalyses the actual proteolytic 
degradation. A survey of the literature reveals that in many cases, exposure of proteins 
to oxygen radicals both in vivo and in vitro leads to increased exposure of hydrophobic 
surfaces (Wolff et aL, 1986, Davies, 1987), which may lead to subsequent aggregation 
and to increased susceptibility to proteolysis (Davies, 1987, Strake-Reed and Oliver, 
1989, Stadman, 1992, Rivett, 1985). Conformational changes may also be involved in 
this process (Amado et aL, 1984) and it was found that about two radical events per 
molecule of BSA suffice to cause conformational changes detectable in fluorescence 
spectra and increase in susceptibility to proteinases (Wolff et aL, 1986). Hydroxyl 
radical can induce this increased hydrdlytic susceptibility both in the presence and 
absence of superoxide radical as well as by a variety of peroxy radicals. Thus, both 
fragmentation and cross-linking conditions can induce increased susceptibility. 
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Does Radical Damage Influence Protein Breakdown in vivo? 
A number of processes known to occur in vivo may contribute either directly or 
indirectly to the formation of damaging free radicals. Examples include the respiratory 
burst of phagocytes (Clark et al., 1985) and mitochondrial electron transport (Dean and 
PoUak, 1985). Mitochondrial degradation during reticulocyte maturation seems to 
depend on radicals produced by an endogenous lipoxygenase (Rapoportetal., 1985). 
Furthermore, Dean and Pollak (1985) found that isolated rat liver mitochondria in state 
four (limited by availability of ADP) degrade their endogenously synthesized protein 
faster when radical fluxes are enhanced (by chain blockers and uncouplers) as compared 
to when they are minimized. In few cases, endogenous agents which may increase 
radical generation, are known to enhance proteolysis for instance, phenylhydrazine 
increases breakdown of hemoglobin in reticulocytes (Goldberg and Boches, 1982). It has 
also been shown that free radicals can fragment monoamine oxidase, a protein in outer 
mitochondrial membrane, (Dean etal., 1986). Cellular proteolysis requires ATP and so 
changes in ATP concentration can mfluence proteolysis. It is interestmg that depletion of 
cellular reductants (such as NADH and reduced glutathione) is often associated with 
enhanced proteolysis (Khairallah et aL, 1984). One explanation would be the decreased 
repair of protems damage under conditions of oxidative stress. Similarly, zinc is known 
to possess some antioxidant properties and there can be an inverse correlation between 
zinc status and proteolytic rate (Wolff et al., 1986). Model antioxidants such as vitamin 
E, have been shown to play a critical role in retarding radical induced proteolysis 
particularly that, involving lipid intermediates (Dean and Cheeseman, 1987). 
Other Possible Consequences Of Damage To Proteins By Radicals: 
Because of the catalytic role of many proteins, Wolff etaL, (1986) have suggested 
that damage to proteins may also be important at least in the short term and probably in 
the long term because proteins regulate gene expression. The extreme case of the 
possible relevance of protein damage is in cell lysis. Free radical fluxes can lyse cells. 
'Professional phagocytes' generate such a flux at the cell surface for killing bacteria and 
parasites (Wolff et al., 1986) it thus, has been suggested that the critical targets of such a 
mechanism, might be transport proteins in membranes. A limited radical attack on a 
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critical transport protein might cause a greatly amplified effect on the ionic homeostasis 
of the cells, which resuUs in osmotic lysis. Radical attack on some cell types results in 
damage to surfece proteins (Clark, et al,, 1985). 
LIPID PEROXIDATION: 
The deleterious effects of oxidative damage on proteins and lipids are of paramount 
interest in biological and biomedical research (Halliwell and Gutteridge, 1986, 
Frido\-ich, 1986, Kontos, 1985, Gaudel and Divelleroy, 1984). Oxidative stress induces 
numerous types of alterations in biological membranes. Among the many structural 
manifestations, peroxidation of lipids is one (Kappus, 1985). Lipid peroxidation results 
in a variety of biochemical and biophysical changes in the membrane (Plaa and Witschi, 
1976, Vladimirov et al, 1980). Various biochemical changes concomitant upon 
peroxidation are inhibition of membrane boimd enzymes (Stadman, 1986, Okabe et al., 
1983), as well as the loss of barrier functions (Deuticke et al., 1986, Okabe et al., 1983, 
Grankvist and Marklund, 1986). The various biophysical consequences reported are 
changes in membrane fluidity (Bruch and Thayer, 1983) and rigidification of membrane 
skeleton (Shohet and Mohandas, 1985). 
Lipid peroxidation occurs both enzymatically and nonezymatically (Kim et aL, 1988). It 
was reported that nonenzymatic autooxidation yields random hydroperoxide isomers that 
are implicated in certain types of membrane pathologies, while the enzymatic 
peroxidation of pohiinsaturated fetty acids in biomembranes is a controlled process that 
yields specific positional and configuration isomers of hydroperoxide. The two most 
important and well studied enzymatic lipid peroxidation systems are the NADPH-
dependent lipid peroxidation, where reducing equivalents are provided by the NADPH-
cytochrome P reductase catalyzed reduction of iron by NADPH (Chiu et al., 1976), and 
superoxide dependent lipid peroxidation, where reducing equivalents are provided by 
xanthine oxidase catalyzed reductionof superoxide radical by xanthine (Chatterjee and 
Agarwal, 1988). 
Lipid peroxidation appears to be a primary process in a variety of pathological events 
including aging (Ames, 1983, Halliwell, 1984), Batten's syndrome (Zeman, 1971), liver 
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injury caused by ethanol (Dio Luzio and Hartman, 1969) or chlorinated hydrocarbons 
(Rechnagal, 1967). Some phases ofatherosclerosis may also involve lipid peroxidation 
(Fujii and Sati, 1971). It is considered to play a key role in the development of cardiac 
lesions arising from myocardial infarction, ischemia and severe stress (Meerson et al., 
1981, Chien et al., 1979, Cohen, 1989) cancer (Mcbrien and Slater, 1982), and sickle 
cell anemia (Katsumata et al., 1990). 
Mechanism of Lipid Peroxidation: 
Biological membranes containing polyunsaturated fatty acids and bathed in an oxygen 
rich and metal ion containing fluids, are good targets of peroxidation (White, 1973, 
Chatterjee and Agarwal, 1988). Butylated hydroxy-toluene completely prevent oxidation 
of endogenous polyunsaturated fatty acids but didn't completely prevent hemolysis 
indicating that factors other than lipid peroxidation are also important in lysis of RBC. 
Lipid peroxidation is a complex process characterized by three distinct phases (a) slow 
mduction phase (b) a rapid propagation phase catalyzed by transition metal ions like 
copper or iron (c) a slow termination phase (Gutteridge, 1982, Pryor, 1976). 
Free radicals in the presence of oxygen can degrade lipids by peroxidative injury. Free 
radical initiators are capable of extracting hydrogen atom from unsaturated fetty acids, 
generating a free radical. This results in electronic instability and rearrangement of 
existing bonds resuking in the formation of conjugated diene (Barber, 1968). This may 
be followed by the addition of oxygen to the diene to form the fatty acid peroxyl radical 
which can be converted mto lipid endoperoxide (Hatherill et al., 1991). A postulated 
sequence of events with polyunsaturated fatty acids is shown in Fig. 2. The ground state 
of polyunsaturated fetty acids is of singlet muUiplicity and their reaction with oxygen is 
spm forbidden since the ground state of oxygen is of triplet multiplicity. The lipid 
peroxidation reaction thus involves a mechanism that circumvents the spin barrier. It 
occurs via a free radical mechanism and proceeds by chain reaction (Chatteridge and 
Agarwal, 1988). A single hit of the initiating radical induces the oxidation of many 
molecules of fatty acid thus amplifies the oxidative damage. 
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Fig. 2. Mechanism of lipid peroxidation. 
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Additionally, the peroxyl radical can react with another unsaturated fatty acids 
producing a lipid hydroperoxide and other alkyl radicals. Hydroperoxide can decompose 
and form radical resulting in amplification of oxidative damage to the membrane. 
Furthermore, incomplete removal of water soluble hydroperoxide such as hydrogen 
peroxide will also result in increased radical formation, which could lead to oxidative 
damage in the cytosol or the membrane compartment. Hydrogen peroxide is a 
physiological hydroperoxide that is formed continuously in various organs and in the 
RBC through dismutation of superoxide radical 
Lipid Peroxidation in RBC: 
The red blood cells are the fevorite objects to study lipid peroxidation both in vivo and 
in vitro. Use of the RBC, as a model system is physiologically relevant because it is 
normally exposed to high intracellular and extracellular p02 in vivo (Dise and Goodman, 
1986). In addition, RBC are directly exposed to ingested drugs, inhaled gases and 
activated neutrophils which are capable of generating free radicals in the circulation 
(Chiu et aL, 1982, Claster et al., 1984). Induced oxidative membrane changes in RBC 
are of interest because they serve as model for RBC membrane changes in various 
pathological conditions and hematological diseases e.g. thalassaemia, sickle cell anemia 
(Deuticke et al., 1987). As the RBC memtwane is rich in polyunsaturated fetty acid and 
is continuously exposed to high pOa, they are highly susceptible to oxidation. 
Porter (1986) reported that lipid peroxidation caused the conversion of thecis, cis-
double bonds to cis, trans or trans, trans-double bond. Niki et al.(1988) have shown that 
phospholipids as well as proteins are affected during the peroxidation ofRBC and as it 
proceeds, K* leaks out, followed by the leakage of Ca^ ,^ lactate dehydrogenase, aspartate 
transaminase and eventually hemolysis sets in. Increased RBC membrane permeability 
has also been reported by Chiu et al. (1982) as a consequence of lipid peroxidation. 
RBC lipid peroxidation has also been shown to cause cellular dehydration and reduced 
in vivo RBC survival (Jain et al., 1983), reduced whole cell deformability (Pfefferott et 
al., 1982, Jain et al., 1983) and increased hemoglobin binding to the RBC membrane 
(Sauberman et al., 1981). 
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The oxidation of RBC by hydrogen peroxide, xanthine oxidase, organic 
hydroperoxide has been studied extensively. They have been shown to induce hemolysis 
and membrane damage (Koster and Sell, 1983). Hydrogen peroxide is known to induce 
lipid peroxidation (Evelo et al., 1998). Jain, (1984) observed that in vitro peroxidation of 
RBC membrane by hydrogen peroxide led to the accumulation of MDA and 
destabilization of phospholipid organization by extemalization of aminophspholipids 
(phosphatidylserine and phosphatidylethanolamine) that are confined to the inner leaflet. 
Earlier Jain and Hochstein, (1980) demonstrated that MDA causes marked reduction m 
RBC membrane spectrin, which plays a major role in the maintenance of asymmetric 
phospholipids distribution across thebilayer(HaestetaL, 1978). Thus the disturbances 
observed by Jain, (1984) in phospholipids asymmetry could be accounted partly by the 
spectrin reduction by MDA and partly due to nonimiform distribution of cross-links 
formed between MDA and aminophospholipids through schiff s base. 
Kuppfer cells. Fibroblasts and invading leukocytes are a major source of ROS 
(Pietrangelo, 1996). By attacking polyunsaturated fatty acids of membrane 
phospholipids free radicals of these lipids are formed as well as their respective proxy 
radicals. Following this initiation of lipid peroxidation transition ions, such as copper 
and iron, are essential in the subsequent propagation steps (Pietrangelo, 1996). The main 
subsequence of lipid peroxidation of biological membrane are the functional and 
structural modification of the membranes and generation of byproducts such as highly 
reactive aldehydes, from oxidative breakdown of polyunsaturated fetty acids (Estebauer, 
1993). ROS posses tremendous intrinsic reactivity that leads to interaction with cell 
targets close to the site of generation. For instance, hydroxyl radical can diffuse only 5-
10 molecular diameter from its site of formation before it reacts. 
In contrast to these highly reactive free radicals lipid peroxidation by products such as 
aldehydes are rather long lived and can diffuse from the site of formation and reach 
more distant intracellular and extracellular targets. These byproducts may then form 
covalent bonds (adducts) with proteins, there by inactivating them and damagmg the cell 
(Pietrangelo, 1996). 
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THEOPHYLLINE STUDIES: 
Theophylline is widely used in the treatment of asthma (kaneko etaL, 1990). Recently 
reported data have led to the proposal that theophylline has anti-inflammatory effect 
(Adachi et al, 1996). Theophylline significantly inhibits the late asthmatic response, 
after the allergen challenge at the sub bronchodilating level, suggesting that theophyllme 
is likely to modulate bronchial inflammation (Ward et al., 1993). The anti-asthmatic 
action of theophylline is thought to be mediated by the inhibition of cyclic nucleotide 
phosphodiesterase, leading to an accumulation of cAMP, \vhicli subsequently causes 
bronchiodilation through the activation of cAMP-dependent protein kinase A. 
Theophylline however, is a weak bronchodilator compared to 32-adenoreceptor agonist 
and other activities of theophylline which include antagonism of adenosine, transient 
increase in adrenaline levels, possible inhibition of Cst^ influx, transient decrease in 
puhnonary artery pressure, stimulation of central respirati6n and improvements in the 
efficiency of diaphragmatic contraction and mucociliary clearance, may all play a 
beneficial role in its efficacy (Barnes and Pauwels, 1994, Persson and Pauwels, 1991). 
Recently theophylline has also been shown to exhibit immunomodulatory effects 
(Barnes and Pauwels, 1994, Persson and Pauwels, 1991, Kidney et aL, 1995, Sullivan et 
aL, 1994, Ward et al., 1993) and it is possible that it may have an additional mode of 
action namely, as an anti-inflammatory agent (Mahomed et aL, 1998). The mechanism 
of this anti-inflammatory action has not however, been clearly elucidated. A number of 
mechanisms including inhibitory effect on the release of inflammatory mediators (Kraft 
et aL, 1996, Ohta et al., 1996, Spatafora et al., 1994) as well as on activation of T cells 
(Ward et al., 1993), macrophages (Dent etal., 1994) and granulocytes (Nielsonetal., 
1988) have been postulated. 
Dent et al., (1994) have shown that theophylline mhibits the respiratory burst of alvealor 
macrophages by elevation of cAMP, while Nielson et al. (1988)andDetongietaL, 
(1984) have reported similar cAMP-dependent negative effect of this agent on 
neutrophils activation- However, other authors have reported conflicting results with 
either no mhibition, or in some cases even enhancement of the neutrophils respiratory 
burst by theophylline and aminophylline (Kaneko et al., 1990, Kato et al., 1991, 
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Llewellyn-Jones and Stockley, 1994). Theophylline at a therapeutic concentrations 
causes increased level of cAMP and dose related inhibition of superoxide radical 
generation by human neutrophils (Mahomed et al., 1998). Since neutrophil derived 
reactive oxidants caused damage to the respiratory epithelium in a number of respiratory 
diseases, including asthma and chronic obstructive airway diseases, these account at 
least in part, for the beneficial anti-inflammatory effects of the theophylline seen in these 
respiratory disorders (Mahomed et al., 1998). 
Theophylline may exert anti-inflammatory properties by inhibiting inflammatory 
reaction following allergic challenges (Ward et al., 1993) and neutrophils inactivatioa It 
has been shown to block synthesis and release of tumor necrosis factor a and 
interleukin-1 P by human mononuclear cells (Endres et al., 1991) and promote apoptosis 
in interleukin-5 stimulated eosinophils (Adachi et al., 1996). The anti-inflammatory 
mode of action of theophylline can be accounted for its ability to inhibit the L-argiuine 
dependent production of nitric oxide in patients with asthma (Sansone et al., 1998). 
The currently used anti-asthmatic drugs do exert direct inhibitory effect on human 
eosinophils, at least in an in vitro setting. These effects depend to a large extent on the 
stimulus used as well as the response being measured (Ezeamuzie and Al-Huge, 1998). 
In general however, they were by fer more effective in inhibiting superoxide radical 
release, perhaps through direct inhibition of the NADPH oxidase than degranulation. 
Thus, the extent to which these drugs act on human eosinophils may contribute to their 
in vivo anti-asthmatic efficacy will and depend, to a large extent on the impact of 
oxygen-derived fi-ee radicals on the pathophysiology of the disease (Ezeamuzie and Al-
Huge, 1998). 
Free radicals released from human eosinophils is enhanced by theophylline at a 
clmically relevant concentrations (10"^ -10"^  M) (Pauwels et al., 1985). These free 
radicals can then react with administered drug such as theophylline (Crucq and Tilquin, 
1996). ROS have attracted increasing attention for their possible role in promoting 
inflammation in a variety of puhnonary diseases including asthma (Calhoun and Bush, 
1990). However, ROS metaboUsm of phagocytic cells may be substantially modified by 
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therapeutic agents used for asthma (Calhoun and Bush, 1990). Studies in cats have 
shown that oxygen radicals may directly induced bronchoconstriction and airway hyper 
responsiveness (BCatsumata et al., 1990). Thus, the study of air space cells ROS 
metabolism is relevant to pathogenesis of asthma. Data derived from peripheral blood 
mononuclear cells and alveolar macrophages rather than eosinophils, showed inhibition 
of superoxide radical released by relatively high doses of theophylline. In contrast, 
eosinophils release of superoxide radical was enhanced by lower theophylline doses 
(Yukawa et al, 1989). Several mechanisms could be involved in down regulatmg 
alveolar macrophage superoxide radical release by theophylline. 
Recent studies have shown that riboflavin in the presence of Cu(II) caused hemolysis of 
human RBC (Ali et al., 2000) and degradation of proteins (Jazzar and Naseem, 1994). 
These studies clearly indicated the toxic potential of riboflavin. However, the molecular 
mechanisnK associated with the interaction of riboflavin with living cell and 
macromolecules under different physiological conditions especially during phototherapy 
are poorly understood. 
ei 
MA TERIALS AND METHODS 
MATERIALS: 
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Acetic acid 
Acrylamide 
Aminophylline 
Ammonium per sulphate 
Ammonium sulphate 
Bathocuproine 
Beia-caroteTie 
Beta-mercaptoethanol 
Bis-acrylamide 
Bovine serum albumin (BSA) 
Catalase 
Coomassie brilliant blue 
Cupric chloride 
Deoxy ribonucleic acid, 
Calf thymus, (DNA) 
D-Glucose 
Diphenyl amine (DPA) 
Ethylene diamine tetra acetic 
Folin's phenol 
Glycine 
Iso-propanol 
Mannitol 
Methanol 
N, N'-methylene bisacrylamide 
Nitro blue tetrazolium (NBT) 
Perchloric acid 
Potassium iodide (KI) 
Riboflavin 
Sodium azide (NaNs) 
Sodium car"bonate 
Sodium chloride (NaCl) 
Qualigens Fine Chemicals, India. 
SRL, India. 
Priya pharmaceutical, India. 
SRL, India. 
BDH, India. 
Sigma Chemical Co., USA. 
Sigma CVifiimka\ Co., USA.. 
E. Merck, India. 
SRL, India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
BDH, India. 
Sigma Chemical Co., USA. 
SRL, India. 
BDH, India. 
S. D. Fine Chem., India. 
BDH, India. 
SRL, India. 
Qualigens Fine Chemicals, India. 
Qualigens Fine Chemicals, India. 
Qualigens Fine Chemicals, India. 
Hi Media Ltd., India. 
Sigma Chemical Co., USA. 
Qualigens Fine Chemicals, India. 
BDH, India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
B"DH, India. 
BDH, India. 
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Sodium dodecylsulphate (SDS) 
Sodium hydroxide (NaOH) 
Sulfuric acid 
Superoxide dismutase (SOD) 
Thiobarbituric acid (TBA) 
Thiourea 
Trichloroacetic acid (TCA) 
Tris (hydroxymethyl) aminomethane 
Sigma Chemical Co., USA. 
BDH, India. 
BDH, India. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
Sigma Chemical Co., USA. 
Glaxo, India. 
Sigma Chemical Co., USA. 
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METHODS 
Preparation OfRBC: 
RBC were prepared from fresh human blood collected in acid citrate dextrose by 
centrifugation at 1500 xg for 10 minutes at room temperature. The cells were washed 
three times with 5 volumes of isotonic NaCl solution and suspended in the desired 
buffer. 
Measurement Of K* Loss: 
Packed RBC were suspended in 3 mlof 10 mMTris-HCl,pH 7.4, containing 0.15 M 
NaCI, varying amounts of riboflavin, Cu(II), sodium azide or aminophylline to give 
0.5% hematocrit. The reaction mixture was incubated at room temperature in 800 lux of 
cool fluorescent light. 
After centrifiigation at 1500 xg for 10 minutes the concentration of K^  was measured in 
the supernatant using EEL flame photometer (Evans Electroselenium, Halested, Essex, 
UK). For reference of 100% K^  loss, a sample of RBC was hemolysed in distilled water 
and K^  concentration determined in the supernatant after centrifiagation as above. 
Measurement Of Hemolysis: 
The percent hemolysis following different treatment ofRBC was measured by reading 
the absorbance of the hemolysate at 415 run as described by Yoshida et al. (1994). For 
reference, RBC were treated with distilled water to obtain 100% hemolysis and the 
hemolysate read at 415 rurt all the experiments were carried out in triplicate and the 
main values are reported. 
Wherever specified, varying amount of free radical scavengers, different metals or 
bathocuproine were included in the reaction mixture (see legends for deteiils). 
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Preparation Of RBC Membrane: 
RBC membrane was prepared by the method of Fairbanks etaL (1971) which is based 
on the principles of hypotonic lysis described by Dodge (1963). The washed RBC were 
hemolysed by mixing rapidly 1 ml portion of the RBC with 40 ml of cold 5 mM Tris-
HCl, pH 7.4, the suspension was centrifuged at 12,000 xg for 30 minutes in a 
refrigerated centrifuge. The resultmg deep red supernatant was aspirated leaving the 
cream colored button. After 3 washes under the same conditions the pellet was collected 
and used as it is for further experiments. 
Induction Of Lipid Peroxidation: 
Lipid peroxidation measured by the method of Parinandi et al. (1990) with few 
modifications. Lipid peroxidation in the human RBC was induced by riboflavin and if 
present Cu (II) and NaNa. All the reactions were carried out in a 1.0 ml final volume 
consistmg of 10 mM Tris-HCl, pH 7.4, 100 nl of packed RBC and different 
concentration of riboflavin, Cu(II) and sodium azide. All the incubations were carried 
out at room temperature in fluorescent light. Control sample was incubated in the 
absence of riboflavin. 
In all the experiment where inhibition of lipid peroxidation by antioxidants was studied, 
various antioxidants were added simultaneously with riboflavui and riboflavin-Cu (II) 
system to the reaction mixture. 
Estimation Of Lipid Peroxidation: 
MDA, the end product of fetty acids peroxidation reaction, can react with TBA to form a 
colored complex that has maximum absorbance at 532 nm. TBA reactivity of RBC 
membrane was determined by the modifiedmethodof Stocks and Mormandy( 1971). 
For this purpose appropriate aliquots of packed RBC were suspended in 1.0 ml of 10 
mM Tris-HCl saline buffer, pH 7.4, containing varying concentrations of riboflavin, 
Cu(II) and NaNs. The reaction was incubated for the indicated time intervals in 
fluorescent light. To this was added 0.5 ml of 30% TCA. Tubes were vortexed and 
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allowed to stand in ice for at least 2 Vi hours. The tubes were then centrifiiged at 2000 xg 
for 15 minutes and 1 ml of supernatant was transferred from each tube. To this was 
added 0.075 ml of 0.1 M EDTA and 0.25 ml of 1% TBA in 0.05 M NaOH. The tubes 
were mixed and kept in a boiling water bath for 15 minutes. Absorbance was read at 532 
nm in DU-40 spectrophotometer after the tubes were cooled at room temperature. EDTA 
was added to chelate any metal ion, such as iron or copper in the extract which otherwise 
might initiate lipid peroxidation during boiling and results in falsely elevated values. 
MDA concentration was calculated using Em values of 1.56 X 10^  M "Vcm (Jain, 1988). 
SDS-Polyacrylamide Gel Electrophoresis: 
SDS-PAGE was performed essentially, according to the method of Laemmli (1970). 
Stock solutions of 30% acrylamide containing 0.8% bis-acrylamide, 1 M Tris-HCl, pH 
8.8 and 10% SDS were prepared to make 3-15% gradient or 10% SDS gel for membrane 
and BSA respectively. They were mixed in appropriate order and proportions and 
poured with the help ofperista pump into the mould formed by two glass plates (8.5 x 
10 cm) separated by 1.5 mm thick spacers. Bubbles and leaks were avoided. A comb 
providing a template for 7 sample wells was inserted into the stacking gel solution 
before polymerization began. When the polymerization was complete in about 1 hour, 
the comb was removed and wells were overlaid with running buffer. Protein samples 
were prepared to give a final concentration of 1% (w/v) SDS, 0.5% (v/v) (5-
mercaptoethanol, 0.0625 M Tris-HCl pH 6.8 and 10% (v/v) glycerol. A trace of 
bromophenol blue was added as a tracking dye. Samples were then heated in a boiling 
water bath for about 3 minutes and applied to the wells. The electrode buffer contaming 
0.025 M Tris-HCl, 0.2 M glycine and 0.2% SDS. Electrophoresis was performed 
initially at 50 V for 15 minutes and then at 100 V till the tracking dye reached the 
bottom of the geL After the electrophoresis was complete BSA bands were detected by 
staining the gels with 0.1% coomassie brilliant blue R-250 in 40% methanol and 10% 
acetic acid. Destaining was carried out withl0% glacial acetic acid. The RBC membrane 
gels were stained with silver nitrate method (Okley et al. 1980). 
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Preparation Of Pea Seeds Nuclease: 
Germination of seeds: 
The seeds were surface sterilized in 0.01% (v/v) mercuric chloride solution and washed 
thoroughly with distilled water. The sterilized seeds were imbibed over night in distilled 
water. The sterilized seeds were then transferred for germination to sterile dishes lined 
with moist paper incubated at 25 C°. Distilled water was sprinkled every 12 hours. 
Crude enzyme preparation: 
The germinated seedlings were removed at desired intervals, and the crude homogenate 
was prepared by suspending 83 gms excised embryo axes in three volumes of Tris-HCl 
buffer (0.02 M, pH 8.0) containing 1 x 10"^ M (J-mercaptoethanol (buffer A). They 
were then thoroughly ground in a pre-chilled warring blender imder cold conditions. The 
slurry was passed through folds of cheese cloth. The filtrate was centrifuged at 10,000 
xg for 10 minutes. The supernatant obtained was used as crude extract and further 
processed for purification. All subsequent steps for the enzyme purification were carried 
at4C°. 
Ammonium sulphate fractionation: 
To 365 ml of homogenate (fraction I) 89.91 gms of ammonium sulphate was added and 
dissolved by stirrmg (40% saturation). Ammonium hydroxide was added to maintain the 
pH (8.0). After 4 hourstheprecipitate was removed by centrifugation at 15,000 xg for 
20 minutes. To 290 ml of supernatant, 100.6 gms (80% saturation) ammonium sulphate 
was further added. The solution was again allowed to stand in cold for 4 hours. The 
precipitate was removed after centrifugation at 15,000 xg for 20 minutes and dissolved 
in 60 ml of the same buffer. Sixty ml of dissolved precipitate was extensively dialyzed 
against 3 changes of buffer A (1 litter each) and finally against buffer B (0.0IM Tris-
HCl, pH 7.5) for 12 hours each (fraction II). 
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Reaction Of RiboHavin With Calf Thymus DNA And Digestion With Pea Seeds 
Nuclease: 
Five hundred ng each of native calf thymus DNA prepared in 10 mMTris-HCl was 
incubated in fluorescent light with varying amount of riboflavin and if present Cu(II) 
and NaNs. After incubation for different time intervals at room temperature, pea seed 
nuclease digestion was performed. The assay determined the acid soluble nucleotides 
released from DNA if any as a result of damage caused by riboflavin and other additives 
using pea seed nuclease digestion. The reaction mixture for pea seed nuclease digestion 
contained in a total volume of 1.0 ml, 0.1 MTris-HCI, pH 7.4, 0.001 MMgCk, distilled 
water and enzyme. The reaction mixture was incubated for 2 hours at 37 C°. At the end 
of the incubation the reaction was stoppedbyadding0.2mlof lOmg/mlBSA, mixed 
thoroughly by shaking, and 1 ml of prechilled 14% perchloric acid. The tubes were left 
in ice for at least half an hour, and centrifiiged to remove undigested DNA and proteins. 
Acid soluble nucleotides were determined in the supernatant using the diphenylamine 
method of Schneider (1957). To a 1.0 ml aliquot, 2.0 ml diphenylamine reagent (freshly 
prepared by dissolving 1 gm of recrystaUised diphenylamine in 100 ml of glacial acetic 
acid and 2.75 ml of concentrated sulfuric acid) was added. The tubes were heated in a 
boiling water bath for 20 minutes. The intensity blue color was read at 600 imi. 
Treatment Of RBC Membrane With Riboflavin: 
Freshly prepared RBC membrane was treated with riboflavin in a buffer containing 5 
mM Tris-HCl, pH 7.4. After incubation in fluorescent light, sample dye is mixed with 
the reaction sample, then subjected to 3-15% SDS-PAGE. The gels were stained by 
method of Okley et aL (1980). 
Scanning Electron Microscopy: 
The reaction mixture containing RBC (0.5% hematocrit) treated with riboflavin alone 
and in the presence of different combination as shown in the legends. After 2 hours of 
incubation m fluorescent light RBC from different reactions were applied on special 
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glass slides washed with alcohol and dried. The glass slides were then coated with gold 
by a sputter cotter, then micrographs were taken usuig scanning electron microscope, 
Philips, Japan. 
, Q 
RESULTS 
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Riboflavin causes K^  leakage: 
The incubation of fresh human RBC with increasing concentration of riboflavin (25-150 
|iM) in fluorescent light for six hours resulted in progressive loss of K^  (Fig. 3). K^  
leakage started at 25 ^M riboflavin, and at 50 \LM riboflavin about 50% K^  was leaked 
out in the medium; fiirther increase in riboflavin concentration led only to slight increase 
in K^  loss, where at 150 |iM riboflavin about 65% K* loss was observed. In the light 
protected control samples under same conditions, no K^  loss was observed. For further 
experiments 50 jiM riboflavin was used unless otherwise stated. 
Riboflavin-Cu(II) causes hemolysis: 
The percent K^  loss and hemolysis of human RBC by photoactivated riboflavin and 
increasing concentrations of Cu(II) are shown iu Fig. 4. There was an mitial increase in 
extracellular K*. At 25 [AM Cu(ll) and 50 \xM riboflavin 60% K^  loss was observed 
compare to 50 % caused by riboflavm alone. It stabilized at 50 ^ iM Cu(ll) where 75% K^  
was observed. The maximum K^  loss was observed in the presence of Cu(II) which is 
30% more than when RBC were incubated with riboflavin alone. The presence of Cu(II) 
also induced significant hemolysis in addition to K* loss. It was appreciable at 50 ^ M 
Cu(II) (20%), then increased vnth increasing the concentration of Cu(II). The maximum 
of 45% hemolysis was however, obtained at 100 |xM Cu(II). Further increase in Cu(II) 
did not lead to any significant increase in hemolysis. 
K^  loss and hemolysis are time dependent processes: 
The percent K^  loss and hemolysis in presence of 50 ^ iM riboflavin and 100 |iM Cu(II) 
were determined as a function of time (Fig. 5). K* loss started immediately after the 
incubation. One hour ofincubation with riboflavin and Cu(II) resulted in about 18% of 
the K^  loss in the medium without any significant hemolysis. The hemolysis started after 
a lag of 1 hour incubation in fluorescent light in the presence ofboth riboflavm and 
Cu(II). Increasing the time ofincubation to 2 hours resulted in the release of 38% of 
cellular K* with 5% hemolysis. Further increase in the time ofincubation caused more 
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Fig. 3. Effect of different riboflavin concentrations on K^  loss. RBC were incubated in 3 
ml reaction mixture containing 10 mM Tris-HCl, pH 7.4, 0.15 MNaCl, 25-150 ^M 
riboflavin to give 0.5 % hematocrit. The percentage of K^  loss was measured after six 
hours of incubation in fluorescent light (•) and in dark (•). 
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Fig. 4. Percent of K^  loss and hemolysis of RBC induced by riboflavin and different 
concentrations of Cu(II). RBC were incubated with 50 |iM riboflavin and increasing 
concentrations of Cu(II). Hemolysis (•) and K^  loss (•) were monitored after six hours 
of incubation in fluorescent light. 
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Fig. 5. Effect of increasing time of incubation on the K^  loss and hemolysis of RBC 
induced by riboflavin alone and riboflavin-Cu(II). RBC were incubated with 50 |iM 
riboflavin and 100 |j,M Cu(II) for different time intervals. (D) K^-loss, (o)K^-loss 
(without Cu(II)), (•) hemolysis, (•) hemolysis (without Cu(II)). 
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K^  loss and hemolysis. After 6hoursof incubation, 80% of the K^  was lost with 45% 
hemolysis. In the absence of Cu(II), RBC did not exhibit any hemolysis even after 
prolonged incubatioa In the light-protected control sample, loss of K* or hemolysis was 
not observed in the presence of both riboflavin and Cu (II) (not shown). 
The effect of different metals on RBC hemolysis: 
As the presence of Cu(II) resulted in significant hemolysis, it was of interest to see the 
effect of other metal ions on RBC. The effect of different metals on RBC hemolysis in 
the presence of riboflavin is shown in Fig. 6. Metals like Fe(III), Co(n), Mn(II), Zn(II) 
and Ni(II)when used with riboflavin instead of Cu(II), did not cause significant 
hemolysis. Among various metals tested Fe(II) caused 28% hemolysis after 6 hours of 
incubation in fluorescent light andthatisabouthalf of what we observed when Cu(II) 
was present in the reaction. 
The role of Cu (I): 
To investigate the role of Cu(I) in hemolysis reaction, bathocuproine the specific Cu(I)-
sequestering agent was included in the reaction containing riboflavin and Cu(II) (F^. 7). 
Bathocuprome specifically binds to Cu(I) if it is produced in the reaction thereby 
preventing it to participate in the reaction if present. Ten fxM bathocuproine was able to 
inhibit the hemolysis by 40% considering the 45% hemolysis caused by riboflavin-
Cu(II) systems as 100% hemolysis. Complete inhibition of hemolysis was achieved at 30 
HM bathocuproine. 
Hydroxyl radical is the main reactive oxygen specie involved in RBC hemolysis: 
Several free radical scavengers were included in the reaction to identify the major ROS 
participating m the RBC hemolysis (Fig. 8). Difierent scavengers like KI, a scavenger of 
triplet oxygen; SOD, a scavenger of superoxide radical; catalase, scavenger of hydrogen 
peroxide; P-carotene, scavenger of both nitric oxide and singlet oxygen, and maimitol 
and thiourea, both scavengers of hydroxyl radical were used, KI showed 60% inhibition. 
48 
Fig. 6. Effect of different metals on RBC hemolysis induced by riboflavin. RBC were 
incubated with 50 ^M riboflavm and 100 nM of Fe(III), Mn(II), Ni(II), Co(n) or Zn(II) 
for 6 hours in fluorescent light. 
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Fig. 7. Effect of bathocuproine on the hemolysis of RBC induced by riboflavin and 
Cu(II). RBC were incubated with 50 (iM riboflavin, 100 |iM Cu(n) and varying 
concentrations (10-50 |iM) of bathocuproine. After 6 hours of incubation in fluorescent 
light, hemolysis was determined and compared with a control lacking bathocuproine. 
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Fig. 8. Inhibition of RBC hemolysis by various free radical scavengers induced by 
riboflavin and Cu(II). RBC were incubated with 50 ^M riboflavin and 100 nMCu(II) 
and 0.1 mM of either mannitol, thiourea, KI, P-carotene or 20 jig/ml of SOD or catalase. 
The incubation was for six hours in fluorescent light. 
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SOD showed 52% inhibition, P-carotene and catalase did not show any significant 
inhibition. Mannitol and thiourea showed 63% and 93% inhibition respectively. The 
reaction was incubated for 6 hours in fluorescent light with riboflavin and Cu(II). 
Sodium azide stimulate RBC hemolysis caused by riboflavin-Cu(II) system: 
The incubation of human RBC in fluorescent light for 3 hours with 50 [iM riboflavin, 
100 nM Cu(II), and increasing concentration ofsodium azide resulted in progressive 
loss of K^  and a significant hemolysis (Fig. 9). There was an initial increase in 
extracellular K* and at 100 nM sodium azide 100% K^  was lost out in the medium. At 
this stage 60% hemolysis was observed. At 150 |j.M sodium azide, maximum hemolysis 
(75%) was obtained. Further increase in sodium azide concentration did not result in any 
significant increase in hemolysis 
The percent hemolysis was also determined in the presence ofriboflavin, sodium azide 
and increasing Cu(II) concentrations. Increasing the Cu(II) concentration resulted in 
increase the rate of hemolysis which stabilized at 100 |xM Cu(n) (Fig. 10). The above 
reaction when incubated in dark did not show any hemolysis. However, in the absence 
of Cu(II) and in the presence of both riboflavin and sodium azide, no hemolysis was 
observed even after a prolonged incubation (data not shovm). 
The percent K* loss and hemolysis in the presence of 50 nM riboflavin, 100 JAM CU(II) 
and 150 |iM sodiimi azide were determined as a function oftune of incubation under 
fluorescent light (Fig. 11). After2hoursof incubation almost all K^  was leaked out in 
the medium with 35% hemolysis. Increasing the time of incubation to 4 hours resulted in 
75% hemolysis. In light protected control samples, no K* loss or hemolysis was 
observed even after prolonged incubation (not shown). 
Involvement of Cu (I) in the reaction: 
In order to investigate whether Cu(I) plays a role in hemolysis caused by riboflavin, 
Cu(II) and sodium azide. The Cu(I) sequestering agent, bathocuproine was included in 
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Fig. 9. Effect of increasing concentrations of NaNs on K^  loss and hemolysis. RBC were 
incubated in 3 ml buffer containing 10 mM Tris-HCl, pH 7.4, 0.15 MNaCl, 50 ^M 
riboflavin, 100 [iM Cu(II) and 25 -200 iiM NaNs to give 0.5 % hematocrit. The 
percentage of K* loss (•) and hemolysis (•) v^ ere determined after 3 hours of incubation 
in fluorescent light. 
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Fig. 10. Effect of increasing concentration of Cu(II) on RBC hemolysis induced by 
riboflavin and NaNs. RBC were incubated with 50 jiM riboflavin, 150^MNaN3and 
increasing concentration (25-150 [iM) of Cu(II). The percent hemolysis was measured 
after 3 hours of incubation in fluorescent light (•) and in the dark (•). 
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Fig. 11. Effect of increasing time of incubation on K^  loss and the hemolysis induced by 
riboflavin, Cu(II) and NaNs. RBC were incubated with 50 ^M riboflavin, 100 |iM Cu(II) 
and 150 i^ M NaN3 for different time mtervals in fluorescent light and K^  loss (•) and 
hemolysis (•) were determined. 
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the reaction (Fig. 12), The effect of bathocuproine was determined by measuring the 
inhibition of RBC hemolysis. Complete inhibition of hemolysis was achieved at 60 \iM 
bathocuproine. 
Effect of various metals: 
To find out whether the effect of riboflavin, Cu(II) and sodium azide is restricted to the 
presence of Cu(II) or other metals can substitute Cu(II), different metals were used in 
place of Cu(II) (Fig. 13). Among these metals Fe (III) was causing 48% hemolysis in the 
presence of riboflavin and sodium azide. Other metals like Co(II), Mn(II), Ni(II) and 
Zn(II) were causing only 20-30% hemolysis. 
Inhibition by free radical scavengers: 
Several free radical scavengers were used to identify the major ROS participating in 
RBC hemolysis by riboflavin, Cu(II) and sodium azide (Fig. 14). Scavengers like SOD, 
catalase and P-carotene did not show significant inhibitioa However, KI gave 38% 
inhibition of hemolysis. While thiourea the scavenger for hydroxyl radical was very 
effective showing 85% inhibition to hemolysis. 
BSA degradation by riboflavin, Cu (II) and sodium azide: 
We have also studied the effect of sodium azide on BSA in the presence of riboflavin 
and Cu(II) (Fig. 15, a & b). This was done to find out whether the effect of sodium azide 
is restricted to RBC system or it can fiinction in vitro and on other systems also. 
Riboflavin alone caused only a slight degradation of BSA (lane 2) while in the presence 
of Cu(II) caused some enhancement of BSA degradation (lane 3). However, BSA is 
con^jletely degraded when sodium azide is included in the reaction (lane 4) and this 
effect is ahnost completely inhibited by thiourea (lane 5). The degradation of BSA is 
enhanced in all cases after increasing the time of incubation from 2 hours (Fig. 15, a) to 
4 hours (Fig. 15, b). Irradiation of BS A ilfihepr^eric^ of sodium azide alone has no 
effect (data not shown). / ^ \ \ 
I [ Ace. No '^1 
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Fig. 12. Effect of bathocuproine on the hemolysis of RBC induced by riboflavin, Cu(II) 
and NaN3. RBC were incubated with 50 i^M riboflavin, 100 fiM Cu(n), 150 |iM NaNs 
and varying concentrations (10-80 jiM) of bathocuproine. After 3 hours of incubation in 
fluorescent light, percent hemolysis was determined and compared with a control 
lacking bathocuproine. 
100-
90 -
80-
^ 70-
^ 60-
o 
2 50-
s: 
c 
~ 40-
30-
20 -
10-
n 1 
u ^ 
( ) 10 
1 
20 
.-
1 1 1 1 
30 40 50 60 
Bathocuproine (pM) 
1 
70 
1 " 
80 
57 
Fig. 13. Effect of different metals on RBC hemolysis induced by riboflavin and NaNs. 
RBC were incubated with 50 \iM riboflavin, 150 |iM NaNs and 100 nM of either Fe(III), 
Co(II), Mn(II), Ni(II) or Zn(II) for 3 hours in fluorescent light. 
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Fig. 14. Effect of various free radical scavengers on RBC hemolysis induced by 
riboflavin, Cu(II) and NaNs. RBC were incubated with 50 |iM riboflavin, 100 |iM 
Cu(II), 150 |iM NaNa and 0.1 mM of either thiourea, potassium iodide, P-carotene or 20 
|j,g/ml of SOD or catalase. After incubation for 3 hours in fluorescent light percent 
hemolysis was determined. 
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Fig. 15. Enhancing effect of NaNs on BSA degradation induced by riboflavin and 
Cu(II). BSA (2 mg/ml) was incubated under fluorescent light for 3 hours with 50 |iM 
riboflavin, 100 |iM Cu(II), 150 fiM NaNs and 0.1 mM thiourea. After 3 hours of 
incubation in fluorescent light, 30 |ig protein was analyzed by 10% SDS-PAGE. BSA 
alone (lane 1); BSA and riboflavin (lane 2); BSA, riboflavin and Cu(II) (lane 3); BSA, 
riboflavin, Cu(II) and NaNs (lane 4); BSA, riboflavin, Cu(II), NaNs and thiourea (lane 
5). 
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Absorption spectra of riboflavin in the presence of different scavengers: 
The spectral changes in riboflavin induced by light under different conditions were 
recorded (Fig. 16). Riboflavin as mentioned before exhibits a visible spectrum with a 
major peak of absorbance at 440 nm and a minor peak at 370 nm. Incubation of 
riboflavin under fluorescent light for 30 minutes caused complete disappearance of 
absorption peak at 440 nm. The presence ofCu(II) inhibits the photodegradation and 
restore the peak to some extent. These observations are in agreement with the previous 
reports (Jazzar and Naseem, 1996). However, the addition of sodium azide to the 
reaction containing riboflavin and Cu(II) significantly inhibited the photodegradation 
and restored the 440 nm peak of absorbance to about 85%. 
Riboflavin induced lipid peroxidation in human RBC: 
The objective of the following study is to investigate the effect of riboflavin on MDA 
production, which is the major end product in lipid peroxidation. As evident from Fig. 
17, the exposure of human RBC to riboflavin in fluorescent light resulted in the 
formation of MDA which is progressively increased with increasing riboflavin 
concentration. Significant amount of MDA (3.2 nmol.) was observed with 50 ^M 
riboflavin, after this there was stabilization. 
Addition of Cu (II) to photoilluminated riboflavin is known to generate hydroxyl radical 
via metal-catalyzed Haber-Weiss reaction. In our previous experiments addition of 
Cu(II) was shown to enhance K* loss and induced hemolysis. Here we are interested to 
find out whether Cu(II) also has an enhancing effect on the production of MDA by 
riboflavin. It was clearly seen that the addition of Cu(II) resulted in the enhanced 
production of MDA (Fig. 18). Increasing the Cu(II) concentration to 100 nM resulted in 
about 9 nmol. of MDA compared to 4 nmol. MDA formed in absence of Cu(II). 
Enhancement of MDA production by sodium azide: 
The effect ofsodium azide on MDA production was also studied in the presence of 
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Fig. 16. Absorption spectra of riboflavin under different conditions. Riboflavin alone at 
zero time (1), riboflavinaloneafler 30 minutes of incubation (2), riboflavin and Cu(II) 
afler 30 minutes of incubation (3), riboflavin, Cu(II) and NaN3 after 30 minutes of 
incubation under visible light (4). The concentration of riboflavin, Cu(II) and sodium 
azide were 50 ^M, 100 |iM and 150 \iM respectively. 
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Fig. 17. Effect of increasing concentrations of riboflavin on lipid peroxidation. 100 ^1 of 
packed RBC (10% hematocrit) were suspended in 1 ml of lOmM Tris-HCl, pH 7.4, 0.15 
M NaCl containing 10-90 |iM riboflavin. The amount of MD A was determined after 4 
hours of incubation in fluorescent light (•) and in dark (•). 
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Fig. 18. Effect of increasing concentration ofCu(II) on lipid peroxidation induced by 
riboflavin. RBC were incubated with 50 ^M riboflavin and 25-150 jiM Cu(II) for 4 
hours in fluorescent light. 
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riboflavin and Cu(II) (Fig. 19). Increasing sodium azide concentration resulted in an 
increase MDA production. At 150 \xM sodium azide about 14 nmol. of MDA was 
formed. 
Photoilluminated riboflavin and riboflavin-Cu(II) induced MDA formation was 
determined as a function of time (Fig. 20). There was a slow increase in MDA formation 
in both the cases of riboflavin and riboflavin-Cu(II) followed by rapid increase in MDA 
formation attaining the maximum of 4 runol. and 9 rmiol. within 3 hour with riboflavin 
alone and riboflavin-Cu(ll) system respectively. Addition of sodium azide to riboflavin-
Cu(II), resulted in increased MDA formation to about 12 nmol. after 3 hours of 
incubation. 
Effect of various metals on MDA formation in the presence of riboflavin: 
Cu(II) was replaced by other metals like Fe(III), Co(II), Mn(II), Ni(II) and 
Zn(Il) to find the ability ofthese metals to induce formation of MDA (Fig. 21). Fe(II) 
was most effective giving 7 nmoL of MDA formation followed by Mn(II), Ni(II), Co(II) 
and Zn(ll). The reaction was incubated for 3 hours in fluorescent light. 
Involvement of free radicals in MDA production: 
Several free radical scavengers were used to find the major free radical species 
responsible for causing lipid peroxidation in both riboflavin and riboflavin-Cu(II) 
systems (Figs. 22 & 23). In case of MDA formation by riboflavin alone (Fig. 22), 
catalase was the most effective scavenger showing 60% inhibition followed by SOD 
with 45% inhibition and KI showing 38% inhibition. Thiourea and (3-carotene have no 
significant effect on MDA formation caused by riboflavin alone. 
When Cu(II) is included in the reaction, the effect of scavengers has followed a different 
pattern (Fig. 23). Thiourea was the most effective scavenger showing 62% inhibition 
followed by catalase giving 43%, KI giving 32%, SOD givmg 24% and P-carotene 
giving 3%. The incubation time was for 3 hours in fluorescent light. 
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Fig. 19. Effect of increasing concentration of NaNs on lipid peroxidation. RBC were 
incubated with 50 |iM riboflavin, 100 ^M Cu(II) and 25-200 |LiM NaNs for 4 hours in 
fluorescent light. 
14 
4-
2-
0 
0 25 50 75 100 125 150 175 200 
NaN3 (|JM) 
66 
Fig. 20, Effect of increasing time of incubation on RBC lipid peroxidation induced by 
riboflavin, Cu(II) and sodium azide. RBC were incubated with riboflavin (•) , riboflavin 
and Cu(II) (•) , and riboflavin, Cu(II) and NaN3 (A) for different time intervals in 
fluorescent light. The concentrations of riboflavin, Cu(II) and sodium azide were 50 ^M 
, 100 |iM and 150 |iM respectively. 
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Fig. 21. Effect of different metals on lipid peroxidation induced by riboflavin. RBC were 
incubated with 50 i^M riboflavin and 100 |iM Fe(III), Co(II), Mn(II), Ni(II) or Zn(II) for 
4 hours in fluorescent light. 
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Fig. 22. Inhibition of lipid peroxidation by various free radical scavengers induced by 
riboflavin. RBC were incubated with 50 nM riboflavin and O.lmM of either thiourea, KI 
or P-carotene or 20 lig/ml SOD or catalase. The incubation was for 4 hours in 
fluorescent light. 
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Fig. 23. Inhibition of lipid peroxidation by various free radical scavengers induced by 
riboflavin and Cu(II). RBC v/ere incubated with 50 |iM riboflavin, 100 jiM Cu(II) and 
0.1 mM of either thiourea, KI or P-carotene or 20 ng/ml SOD or catalase. The incubation 
was for 4 hours in fluorescent light. 
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Involvement of Cu(I) in the reaction: 
Bathocuproine the Cu(I) sequestering agent was used to investigate the role of Cu(I) on 
the MDA production (Fig. 24). Bathocuproine when included in the reaction inhibited 
the formation of MDA. Increasing the concentration of bathocuproine resulted in 
decreasing the MDA formation. At 40 jxM bathocuproine, 70% inhibition in MDA 
formation was achieved. Further increase in bathocuproine concentration did not cause 
further inhibition. The reaction was incubated for 3 hours in fluorescent light. 
Effect of riboflavin on human RBC membrane protein: 
The human RBC membrane was prepared as described in the "methods" and was used 
the same day. The membrane was treated with riboflavin and subjected to SDS in 3-15% 
gradient PAGE. When the membrane was incubated in fluorescent light v^ dth 50 jiM 
riboflavin for different time intervals (Fig. 25), there was a remarkable decrease in the 
intensity of all bands. The decrease intheintensity of different bands was significant 
after 4 hours of incubation. Even after 2 hours of incubation there was noticeable 
decrease in the intensity of spectrin followed by slight decrease in the intensity of other 
bands. 
Cu(II) enhanced the degradation of membrane protein: 
The effect of time of incubation in fluorescent light with 25 jj,M riboflavin and 50 jiM 
Cu(II) on RBC membrane polypeptides is shown in Fig. 26. Increase in the time of 
incubation led to progressive loss of spectrin followed by appearance of high molecular 
weight protein. The high molecular weight protein retained at the top in the control lane 
is also disappearing slowly, with increase in the intensity of band 7. At the end of 40 
minutes the intensity of band 7 has increased very significantly compared to control 
lane. 
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Fig. 24. Effect of bathocuproine on RBC lipid peroxidation. RBC were incubated with 
50 \iM riboflavin, 100 |j,M Cu(II) and 10-80 \iM bathocuproine for 4 hours in 
fluorescent light. A control sample in the absence of bathocuproine was taken as 100% 
lipid peroxidation. 
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Fig. 25. Effect of increasing time of incubation on the degradation of membrane 
polypeptides induced by riboflavin. Human RBC membrane was prepared as described 
in the methods. Membrane was exposed to 50 pM riboflavm in fluorescent light for 
different time intervals. 
Lane a: membrane alone. 
Lane b: membrane + riboflavin after 30 minutes 
Lane c: membrane + riboflavin after 60 minutes 
Lane d: membrane + riboflavin after 120 minutes 
Lane e: membrane + riboflavhi after 240 minutes 
a b c d e 
HII 
taSi — 
73 
Fig. 26. Effect of increasing time of incubation on tlie degradation of membrane 
polypeptides induced by riboflavin and Cu(II). Human RBC membrane was prepared as 
described in the methods. Membrane was exposed to 25 i^M riboflavin 50 |iM Cu(II) in 
fluorescent light for different time intervals. 
Lane a: membrane alone. 
Lane b: membrane + riboflavin + Cu(Il) after 10 minutes 
Lane c: membrane + riboflavin + Cu(ll) after 20 minutes 
Lane d: membrane + riboflavin + Cu(ll) after 30 minutes 
Lane e: membrane + riboflavin + Cu(ll) after 40 minutes 
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Hydrolysis of calf thymus DNA by riboflavin and riboflavin-Cu(ll) system: 
Riboflavin upon photoillumination is known to generate sensitive sites in DNA 
(Naseem et al, 1988). The effect was enhanced in tlie presence of Cu(Il). The reaction 
was assessed by recording the proportion of double stranded DNA converted to acid 
soluble nucleotides by pea seed nuclease (Naseem and Hadi, 1987). Control experiment 
has established that heat denatured DNA undergoes 100% hydrolysis following 
treatment with pea seed nuclease whereas native DNA resulted in around 5% 
conversion. We have determined the DNA hydrolysis as a function of riboflavin 
concentration (Fig. 27). At 100 fxM riboflavin, about 55% of DNA were hydrolyzed. 
Increasing the concentration up to 200 (iM riboflavin resulted in about 78% of DNA 
hydrolysis. The reaction was incubated for 4 hours in fluorescent light. 
Addition of 30 ^M Cu(ll) to 100 |j,M riboflavin resulted in the enhancement of DNA 
hydrolysis to 100% (Fig. 28). The percent hydrolysis increased almost linearly upto 4 
hours after a lag of 30 minutes for both riboflavin and riboflavin-Cu(II) system (Fig. 29). 
The effect of sodium azide on DNA hydrolysis: 
It was of interest to find out whether sodium cizide a known singlet oxygen scavenger 
has the same enhancing effect on DNA hydrolysis (Fig. 30), as in case of BSA or K* 
loss and hemolysis of human RBC. Surprisingly sodium azide did not enhance the DNA 
hydrolysis by riboflavin and Cu(II), on the contrary it caused slight inhibition. 
Aminophylline induces hemolysis: 
The incubation of human RBC with 50 pM ribofla\'in and increasing concentration of 
aminophylline for 2 hours in fluorescent light resulted in progressive loss of K* and 
significant hemolysis (Fig. 31). There was an initial increase in the extracellular K\ and 
at 48 fxg/ml aminophylline 100% K"^  leaked out in the medium. At this stage 62% 
hemolysis was also observed. However, further increase in aminophylline concentration 
to 80 ^ig/ml caused about 18% increase in hemolysis. No hemolysis was observed after 
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Fig. 27. Effect of increasing concentration of riboflavin on DNA hydrolysis. 500 ^g of 
native calf thymus DNA incubated with 25-200 |aM riboflavin in a final volume of 1 ml 
of 0.05 M Tris-HCl, pH 7.4. The reaction was incubated for 2 hours in fluorescent light 
(•) and in the dark (•). The % DNA hydrolysis was recorded after treatment with pea 
seeds nuclease. A control sample of denatured DNA after treatment with pea seeds 
nuclease was taken as 100% hydrolysis. 
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Fig. 28. Effect of increasing concentration Cu(ll) on DNA hydrolysis induced by 
riboflavin. 500 ^g native calf thymus DNA was incubated with 100 |iM riboflavin and 
5-40 i^M Cu(II) for 3 hours in fluorescent light. 
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Fig. 29. Effect of increasing time of incubation on DNA hydrolysis induced by 
riboflavin and Cu(II). 500 jig native calf thymus DNA was incubated with 100 (iM 
riboflavin alone (•) , and 100 ^M riboflavin with 30 i^M Cu(II) ( • ) for different time 
intervals in fluorescent light. 
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Fig. 30. Effect of NaNs on DNA hydrolysis induced by riboflavin and Cu(II). 500 ng 
native calf thymus DNA was incubated with 100 (iM riboflavin, 30 ^M Cu(II) and 25-
150 fiM NaNs for 2 hours in fluorescent light. 
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Fig. 31. Riboflavin-aminophylline combination induced K' loss and hemolysis of human 
RBC. RBC were incubated in 3 ml of buffer containing 10 mM Tris-HCl, pH 7.4, 0.15 
M NaCl, 50 |iM riboflavin and 16-112 )ag/ml aminophylline to give 0.5% hematocrit. 
The reaction was incubated for 2 hours. 
(•) K* loss in fluorescent light. 
( •) Hemolysis in fluorescent light. 
(A) Hemolysis in dark. 
100 
^ 90 
•^^—' 
% 80 
>> 
i 70 
(U 
x: 
•D 6 0 
c 
03 
« 50 
w 
o 
£ 40 
3 
i;? 3 0 
ca 
2 20' 
10 
0 1 
( 
/ ^ A A — 
) 16 32 
H^  •" •— 
A ^ ^ 
1 1 1 
48 64 80 
Aminophylline (|jg/ml) 
—•— 
— A — 
— 1 
96 
• 
4 
112 
80 
prolonged incubation time in the absence of aminophylline or in parallel sample 
containing riboflavin and aminophylline when incubated in dark, suggested that the 
reaction is light mediated. 
The percent K"^  loss and hemolysis were found to be time dependent (Fig. 32). After 1 
hour of incubation in fluorescent light, 100% of K^  was leaked out in the medium with 
45% hemolysis. Increasingly the time of incubation to 2 hours resulted in 80% 
hemolysis. 
Involvement of free radicals in the reaction: 
Since photoilluminated riboflavin mediates various damaging reactions via ROS, the 
possible involvement of ROS was tested using different free radical scavengers. 
Thiourea and KI gave 70% and 23% inhibition to RBC hemolysis respectively, when 
present with riboflavin and aminophylline in the reaction (Fig. 33). Other scavengers 
like SOD, P-carotene and catalase did not show significant inhibition. 
Absorption spectra of riboflavin in the presence of aminophylline and thiourea: 
The spectral changes in ribofla\Tn induced by light under different conditions were 
recorded (Fig. 34). Riboflavin exhibits a visible spectrum with a major peak of 
absorbance at 440 nm and a minor peak at 370 nm. Incubation of riboflavin under 
fluorescent light for 30 minutes caused disappearance of absorption peak at 440 nm 
suggesting photodegradation of riboflavin. The presence of aminophylline did not have 
any effect on the disappearance of the peak at 440 nm. Interestingly, the addition of 
thiourea to the riboflavin-aminophylline mixture inhibited the photodegradation of 
riboflavin and restored the peak at 440 nm to a significant extent, thiourea has also 
inhibited RBC hemolysis significantly as shown above (Fig. 33) 
Absorbance spectra of aminophylline in the presence of riboflavin and different 
scavengers: 
To determine whether aminoph> lline undergoes any structural change or exhibits 
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Fig. 32. Effect of increasing time of incubation on K^ loss and hemolysis of RBC 
induced by riboflavin and aminophylline. RBC were incubated with 50 |j.M riboflavin 
and 80 lag/ml aminophylline for different time intervals in fluorescent light. ( •) K"^  loss; 
(•) hemolysis. 
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Fig. 33. Inhibition of human RBC hemolysis by various free radical scavengers. RBC 
were incubated with 50 |_iM riboflavin and 80 |ig/ml aminophylline and 0.1 mM of either 
potassium iodide, thiourea or P carotene or 20 |ig/ml of SOD or catalase. The incubation 
was for 2 hours in fluorescent light. 
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Fig. 34. Absorption spectra of riboflavin in the presence of aminophylline under 
different conditions. 50 nM riboflavin alone at zero time (1), riboflavin and 80 }ag/nil 
aminophylline at zero time (2), riboflavin alone after 1 hour of incubation under 
fluorescent light (3), riboflavin with aminophylline after 1 hour of mcubation (4), 
riboflavin with aminophylline and 0.1 mM thiourea after 1 hour of incubation (5), 
riboflavin and 0.1 mM thiourea after 1 hour of incubation (6). 
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binding to riboflavin during irradiation, the absorption spectrum of aminophylline was 
recorded between 240-300 nm (Fig. 35). Aminophylline exhibit a UV spectrum with a 
peak at 270 nm. Irradiation of aminophylline in fluorescent light for more than 2 hours 
did not cause any change in the absorption peak at 270 nm. Addition of 50 |iM 
riboflavin to the reaction caused a decrease in the peak within 10 minutes of irradiation. 
Moreover, the absorption peak of aminophylline completely vanished in the presence of 
riboflavin after 30 minutes of incubation in fluorescent light. However, the addition of 
sodium azide or KI to the medium inhibited this photodegradation and almost restored 
the peak at 270 nm to 90%, while thiourea did not cause any inhibition to aminophylline 
degradation. 
BSA degradation by riboflavin-aminophylHne system: 
We have studied the effect of riboflavin-aminophylHne combination using BSA as a 
target molecule (Fig. 36). This was studied to find out whether the effect of this 
combination is restricted to RBC damage or it functions in vitro and on other systems 
also. A slight change in BSA took place when it was incubated with riboflavin alone, 
while the presence of aminophylline with riboflavin, caused almost complete 
degradation of BSA into small peptides. The effect is shown by the smearing of the 
major band. The presence of thiourea in the reaction significantly inhibited BSA 
degradation. The irradiation of BSA in the presence of aminophylline alone had no 
effect (data not shown). 
Scanning electron microscopy of RBC treated with riboflavin, Cu(II), sodium azide 
and aminophylline: 
When RBC were treated with riboflavin alone and in the presence of various agents, 
they undergo certain changes in their morphology. Incubation of RBC with riboflavin 
alone resulted in the formation of spherical form of RBC called spherocytes (Fig. 39). 
RBC were incubated with 50 ^M riboflavin for 2 hours in fluorescent light. No clear 
holes or damage was observed in this case. 
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Fig. 35. The absorption spectra of aminophylline illuminated with riboflavin under 
different conditions. The spectra of 80 |J.g/ml aminophylline was recorded between 240-
300 nm after irradiation with fluorescent light in the presence of 50 |iM riboflavin. 
Aminophylline alone at zero time (1), aminophylline and riboflavin at zero time (2), 
aminophylline and riboflavin after 10 minutes of incubation (3), aminophylline with 
riboflavin after 30 minutes of incubation (4), aminophylline and riboflavin with NaNs 
(5) or KI (6) after 30 minutes of incubation, aminophylline, riboflavin and thiourea after 
30 minutes of incubation (7). 
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Fig. 36. Degradation of BSA induced by riboflavin and aminophylline. 2 mg/ml BSA 
was incubated with 50 |iM riboflavin and 80 fig/ml aminophylline in fluorescent light 
for 2 hours. 
Lane a: BSA alone. 
Lane b: BSA + riboflavin. 
Lane c: BSA + riboflavin + aminophylline. 
Lane d: BSA + riboflavin + aminophylline + 0.1 mM thiourea. 
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Fig. 37. A scheme for the photodegradation of riboflavin-aminophyllme and RBC 
damage in fluorescent light. ISC= Intersystem conversion;'[= singlet state; ^ [= triplet 
state; .= n—7t*; R=CH0H-CH0H-CH0H-CH0H-CH20H 
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Fig. 38. Scan electron microscopy of normal RBC. 
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Fig. 39: Scan electron microscopy of riboflavin-treaied RBC. RBC {0.5% hematocrit) 
were incubated vvith 50 )iM riboflavin for 2 hours in fluorescent light. The sample was 
then prepared as described in the methods before using the SEM. 
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When RBC were incubated with 50 ^M riboflavin and 100 |j.M Cu(II), the RBC undergo 
more advanced changes where irregular spikes appeared at the surface of RBC (Fig. 40). 
These structures are called acanthocytes. 
The changes recorded when RBC were incubated with 50^M riboflavin, 100 [iM Cu(II) 
and 150 |i.M sodium azide are shown in Fig. 41. The membrane is showing drastic 
changes and is completely damaged. 
Addition of aminophylline to riboflavin has been shown to enhance the damaging effect 
of riboflavin. The structural changes that are seen in RBC when incubated with 50 nM 
riboflavin and 80^g/ml aminophylline are shown in Fig. 42. RBC surface is modified 
with equally spaced projections over the entire surfece. This formof RBC is called 
"echinocytes". 
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Fig. 40: Scan electron microscopy of RBC treated with riboflavm-Cu(II) system. RBC 
(0.5% hematocrit) were incubated with 50 ^M riboflavin and 100 fxM Cu(II) for 2 hours 
in fluorescent light. The sample was then prepared as described in the methods before 
using the SEM. 
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Fig. 41: Scan electron microscopy of RBC treated with riboflavin, Cu(ll) and NaN3. 
RBC (0.5% hematocrit) were incubated with 50 ^M riboflavin, 100 ^M Cu(II) and 150 
|j,M NaN3 for 2 hours in fluorescent light. The sample was then prepared as described in 
the methods before using the SEM. 

Fig. 42: Scan electronmicroscopy of RBC treated by riboflavin-aminophylline system. 
RBC (0.5% hematocrit) were incubated with 50 jiM riboflavin and 80 jig/ml 
aminophylline for 2 hours in fluorescent light. The sample was then prepared as 
described in the methods before using the SEM. 
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substitute for superoxide radical in the modified metal-catlyzed Haber-Weiss reaction 
(Halliwell and Gutteridge, 1984). 
The adult human body contains about 80 mg of copper (Halliwell and Gutteridge, 1984). 
Copper is absorbed in the intestine and transported by albumin to the liver. After hepatic 
uptake, copper can be incorporated into copper-containing enzymes or ceruloplasmin, 
which can then be transported into the blood (Britton, 1996). Transition metal ions, 
especially copper and iron having frequently unpaired electrons, are excellent catalysts 
and play a decisive role in the generation of strong reactive species from the less reactive 
ones, for instance by catalyzing the formation of hydroxyl radical from superoxide 
radical and hydrogen peroxide (Pietrangelo, 1996). Fortius reason, cells usually keep 
metal ions very firmly bound to proteins (Halliwell and Gutteridge, 1986). The most 
prominent reactions involved in these metal catalyzed hydroxyl radical generations are: 
02-" + M^° ^ 02 + M""^  
H202 + M ° \ • OH- + OH- + M^" 
Net: O2- + H2O2 ^ OH+OH +O2 
The overall reaction is often referred to as the modified metal-catlyzed Haber-Weiss 
reaction. This has been most often studied with iron salts but copper ions will also 
catalyze this reaction; in fact cuprous salts generate hydroxyl radical from hydrogen 
peroxide fester than ferrous salts (Halliwell and Gutteridge, 1984). 
Riboflavin in the presence of Cu(II) and visible light has been shown to cause breakage 
of calf thymus DNA (Naseem et al., 1993) and fragmentation of proteins (Pauwels et al, 
1985, Jazzar and Naseem, 1996). Therefore, the effect of riboflavin on human RBC was 
also studied in the presence of Cu(II). The hemolysis of RBC started after a lag time of 
60 minutes (when K* loss was already 18%) and increased progressively up to sbc hours 
with maximum being 45%. However, after sbc hours the maximum K"^  loss was 80%. 
The effect of Cu(II) on RBC leading to hemolysis may arise from the feet that Cu(II) 
interacts with photoactivated riboflavin to provide a long-Uved excited species. Direct 
charge transfer from excited riboflavin can generate the singlet and triplet oxygen 
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Riboflavin (vitamin B2) is the prosthetic group of several proteins and enzymes where it 
is reversibly reduced by hydrogen atoms. When exposed to light, riboflavin absorbs 
energy and reacts via its triplet excited state with other molecules such as protonated 
substrates or molecular oxygen generating ROS (Frati et al., 1997). These ROS are well 
known for their damaging effect on several biological molecules (Naseemetal., 1993, 
Jazzar and Naseem, 1994). In the present work the effect of photoactivated riboflavin on 
human RBC has been studied. In the presence of riboflavin and visible light, significant 
loss of K" is observed which is probably due to an alteration in the permeability of the 
RBC membrane. Since, no hemolysis was observed under these conditions, this result 
showed that the photosensitized riboflavin rendered the cell membrane permeable to K ,^ 
but not to large molecules like hemoglobin. 
The unique role of metals like iron in the transport and metabolism of oxygen in living 
organisms primarily reflects the ease with which it facilitates electron transfer. Exposure 
of cell to oxygen radicals and the consequent damage is therefore, inseparably associated 
with the life processes. The RBC of higher animals are particularly vulnerable to the 
potential hazards of aerobic environments due to the presence ofhigh concentration of 
iron and polyunsaturated fetty acids in the membrane. Although, the RBC are certainly 
endowed with a number of antioxidants and reduction mechanisms, their ability to 
detoxify oxygen radicals is limited and restricted to conditions in which strict separation 
of metals (iron) and lipids are preserved. Antioxidant defense goes astray when the cells 
become deficient in enzymes that maintain reducing potential of the cell or when 
challenged with strong oxidants or imder severe oxidative stress (Hebbel, 1986). 
In the healthy RBC under normal conditions, the oxidative challenge begins with the 
generation of superoxide radical, arising from the turnover of methemoglobin (Carrel et 
al , 1975). The superoxide radical is readily converted to hydrogen peroxide either 
spontaneously or by the action of SOD. The hydrogen peroxide can react with Cu(II) to 
produce hydroxyl radical and hydroxyl ions. The importance of superoxide radical lies 
in its ability to reduce Cu(II) to Cu(I). Since copper is required for subsequent reactions 
involving hydroxyl radical formation, its availability is critical. Indeed a number of 
naturally occurring reductants like glutathione, flavonoids and ascorbate may potentially 
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substitute for superoxide radical in the modified metal-catlyzed Haber-Weiss reaction 
(Halliwell and Gutteridge, 1984). 
The adult human body contains about 80 mg of copper (Halliwell and Gutteridge, 1984). 
Copper is absorbed in the intestine and transported by albumin to the liver. After hepatic 
uptake, copper can be incorporated into copper-containing enzymes or ceruloplasmin, 
which can then be transported into the blood (Britton, 1996). Transition metal ions, 
especially copper and iron having frequently unpaired electrons, are excellent catalysts 
and play a decisive role in the generation of strong reactive species from the less reactive 
ones, for instance by catalyzing the formation of hydroxyl radical from superoxide 
radical and hydrogen peroxide (Pietrangelo, 1996), For this reason, cells usually keep 
metal ions very firmly bound to proteins (Halliwell and Gutteridge, 1986). The most 
prominent reactions involved in these metal catalyzed hydroxyl radical generations are: 
+n / ^ _i_ \ >r n-1 02- + M "° ^ O2 + M 
H2O2 + M ° \ . • OH- + OH• + M^ 
Net: O2- + H2O2 h, OH-+ OH- + 02 
The overall reaction is often referred to as the modified metal-catlyzed Haber-Weiss 
reaction. This has been most often studied with iron salts but copper ions will also 
catalyze this reaction; in fact cuprous salts generate hydroxyl radical from hydrogen 
peroxide faster than ferrous salts (Halliwell and Gutteridge, 1984). 
Riboflavin in the presence of Cu(II) and visible light has been shown to cause breakage 
of calf thymus DNA (Naseem et al, 1993) and fragmentation of proteins (Pauwels et al., 
1985, Jazzar and Naseem, 1996). Therefore, the effect of riboflavin on human RBC was 
also studied in the presence of Cu(II). The hemolysis ofRBC started after a lag time of 
60 minutes (when K^  loss was already 18%) and increased progressively up to six hours 
with maximum being 45%. However, after sbc hours the maximum K"^  loss was 80%. 
The effect of Cu(II) on RBC leading to hemolysis may arise from the fact that Cu(II) 
interacts with photoactivated riboflavin to provide a long-Uved excited species. Direct 
charge transfer from excited riboflavin can generate the singlet and triplet oxygen 
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(Jazzar and Naseem, 1996). Other ROS like hydroxyl radical or hydroxyl ion are also 
generated in the reaction via a modified Haber-Weiss reaction when Cu(II), water and 
molecular oxygen are present. 
Hydroxyl radical exhibits extreme reactivity and reacts with a wide spectrum of organic 
molecules (Dorjftnan and Adams, 1973, Wilson, 1979). As the hydroxyl radical has a 
short life in the range of 7 x lO''" sec. (Howard, 1972), location of the formation of 
hydroxyl radical in the cell, is therefore, of utmost importance. Available evidence 
suggests that cytoplasmic generation of hydroxyl radical may be relatively harmless to 
the membrane but when generated within or in close proximity of membrane it may be 
critical in cell membrane injury (HebbeL 1986). 
In a previous study (Naseem et al., 1993) it was found that the addition of Cu(II) to 
riboflavin, reaction inhibited the photodegradation of riboflavin aivd in this process Cvi(II) 
was reduced to Cu(I). To see if Cu(I) is also involved in the RBC hemolysis reaction, 
riboflavm-Cu(II) mediated hemolysis was carried out in the presence of bathocuproine, a 
known Cu(I)-sequestering ^ent. Complete inhibition was achieved at 30 ^M 
bathocuproine, confirming once agam that Cu(II) is reduced to Cu(I) and the latter is an 
essential intermediate m the reaction. 
Scavengers of various ROS were also included in the reaction. Thiourea ahnost 
completely and marmitol to a lesser extent prevented hemolysis strongly suggesting that 
hydroxyl radical is the major ROS involved in the RBC hemolysis. However, singlet 
oxygen also played a significant role in hemolysis as KI gave 63% inhibition. This is in 
agreement with a previous report on a bacterial system (Jazzar and Naseem, 1996) 
where a scheme was proposed for photodegradation of riboflavin m which the presence 
of Cu(II) generated singlet oxygen and hydroxyl radical jfrom superoxide radical via 
modified Haber-Weiss reaction. 
Azide radical was used as a model of one-electron, rapid oxidant (Jovanovic et al., 
1995). Azide radical is difficult to detea direalyCPatridgeetal., 1994) and capable of 
oxidizing thiols, other sulfur compounds and phenols (Zhao et al., 1994, Froni and 
Willson, 1994, Alfasiand Schuler, 1985). 
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Sodium azide when included in the riboflavin-Cu(II) reaction caused significant increase 
in hemolysis compare to the reaction where sodium azide was absent. This enhancing 
effect of sodium azide on the reaction is surprising and is in contrast with the expected 
inhibition, as sodium azide is a known scavenger of singlet oxygen (Jazzar and Naseem, 
1996). In our reaction system, the enhancing effect of sodium azide was consistent with 
time and concentration tested. To explore the possible mechanism involved, 
bathocuproine was included in the reaction containing sodium azide. The hemolysis was 
completely inhibited by bathocuproine showing that Cu(II) is reduced to Cu(I) in 
presence of sodiimi azide also. The enhancing effect of sodium azide on RBC hemolysis 
caused by riboflavin-Cu(II) is probably due not only to hydroxyl radical but also to the 
formation of azide radical in the reaction as discussed below. 
The photoactivated riboflavin, in the presence of Cu(II), water and molecular oxygen is 
known to generate hydroxyl radical (Jazzar and Naseem, 1996). This hydroxyl radical 
can then react with azide anion to generate azide radical (Halliwell and Gutteridge, 
1985, Patridge et al., 1994): 
Ns' + OH- ^ N3- + 0H" 
Another possibility is that the singlet oxygen generated via energy transfer from 
photoexcited riboflavin (Jazzar and Naseem, 1996) reacts with azide anion and generates 
azide radical (Pecci et al., 1999): 
'O2 + N3" • N3-+0-2 
There are however, two observations, which suggest that in our system most of the azide 
radical is generated by reaction of azide anion with hydroxyl radical rather than with 
singlet oxygen. First is the ability of thiourea, a hydroxyl radical scavenger, to almost 
completely inhibit the azide radical stimulated RBC hemolysis and degradation of BSA. 
The presence of thiourea probably quenched hydroxyl radical so none was available to 
react with azide anion and produce azide radical. Second was the uihibition of RBC 
hemolysis by bathocuproine, a Cu(I)-sequestering agent. The singlet oxygen is generated 
directly upon photoexcitation of riboflavin and not by modified metal-catalyzed Haber-
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Weiss reaction involving copper ions. Thus, if azide radical vfas generated by reaction of 
azide anion with singlet oxygen, the presence of bathocuproine would not have had any 
effect. Therefore, in the present work it seems likely that azide radical is produced from 
hydroxyl radical and very little (if any) is generated by singlet oxygen. 
Evidence supporting the generation of azide radical also came from spectral studies of 
riboflavin under different conditions. The addition of sodium azide to the reaction 
inhibited the photodegradation of riboflavin to a significant extent. This resulted in 
protection of riboflavm for a longer duration due to which more hydroxyl radical was 
generated, which then reacted with azide anion, and thus more azide radical was 
produced as discussed above. 
We, therefore, propose that the enhancing effect of sodium azide on photohemolysis by 
riboflavin-Cu(II) system is probably due to the generation of azide radical, in addition to 
hydroxyl radical. In a recent report it was shown that the oxidation rate of hypotaurine 
by superoxide radical increased in the presence of sodium azide (Pecci et al., 1999). 
Horseradish peroxidase, in the presence of sodium azide and hydrogen peroxide, 
mediates the one-electron oxidation of azide ion, forming azide radical (Montellano et 
al., 1988). The azide radical produced by the oxidation ofazide anion via horseradish 
peroxidase. Hydrogen peroxide system stimulated the oxidation of the added taurine. 
However, more work is required to conclusively establish the production mechanism of 
azide radical in our system. 
Oxidative stress induces numerous types of alterations in biological membranes. Among 
the many structural manifestations, peroxidation of lipids is one (Kappus, 1985). Lipid 
peroxidation occurs both enzymatically and nonenzymatically (Kim et al , 1988). 
Nonenzymatic autooxidation yields random hydroperoxide isomers that are implicated 
in certain types of membrane pathologies, while the enzymatic peroxidation of 
polyunsaturated fetty acids in biomembranes is a controlled process that yields specific 
positional and configuration isomers of hydroperoxide. Lipid peroxidation appears to be 
the primary process in a variety ofpathological events including aging (Ames, 1983; 
Halliwell, 1984), Batten's syndrome (Zeman, 1971), liver mjury caused by ethanol (Dio 
Luzio and Hartman, 1969) or chlorinated hydrocarbons (Recknagal, 1967). It may also 
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be involved in some phases of atherosclerosis (Fujii and Sati, 1971), and is considered to 
play a key role in the development of cardiac lesions arising from myocardial infarction, 
ischemia, severe stress (Meerson et al, 1981, Chien etal., 1979), sickle cell anemia 
(Hebbel, 1991) and cancer (Mcbrien and Slater, 1982). 
Peroxidation of phospholipids generates MDA and several MDA-like aldehydes and 
ketones, all of which react v^ i^th TBA (Bird and Draper, 1984). However, for the sake of 
simplicity, TBA-reactivity is equated with MDA, since MDA is the major reactive 
product generated during membrane peroxidation (Pradhan etal, 1990). The method 
commonly employed for the detection oflipid peroxidation is based on the reaction of 
TBA with MDA to give a colored complex that has a maximum absorbance at 532 nm. 
Using different concentrations of riboflavin and different tune intervals, we could 
demonstrate a concentration and time dependent increase in the riboflavin-induced 
production of TBA-reactive material in human RBC. When Cu(II) was added to the 
above reaction, it fiirther enhanced the lipid peroxidation. This may be due to the 
formation of hydroxyl radical We report for the first time that sodium azide when 
present in the reaction with riboflavin and Cu(II) has a promoting effect on MDA 
production. The enhancing effect of sodium azide on RBC hemolysis and lipid 
peroxidation caused by riboflavin-Cu(II) is probably due not only to hydroxyl radical 
but also to the formation of azide radical as discussed previously. The formation of azide 
radical could not be confirmed due to its ver\' rapid decomposition and non-availability 
of any trapping or scavenging agent. 
Exposure of cell membrane, fatty acids, or unsaturated food oils to ionizing radiation 
which generate hydroxyl radical, causes rapid lipid peroxidation (Halliwell and 
Gutteridge, 1985). Indeed, this is a major problem in the use of radiation to sterilize 
packed food. Riboflavin is also known to cause lipid peroxidation upon 
photoillumination (Suzuki et al., 1982). When lipid peroxidation caused by riboflavin 
alone was studied inthepresenceofvariousscavengers,catalase was found to be most 
effective showing 60% inhibition followed by SOD and KI. Thiourea was almost 
ineffective giving 10% inhibition. This may be due to the feet that when riboflavin is 
photoexcited it produces superoxide radical under aerobic condition. In aqueous medium 
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superoxide radical reacts with water and hydrogen peroxide is generated, therefore 
catalase showed maximum inhibition followed by SOD. Inclusion of Cu(II) gave a 
different pattern with various scavengers. Here, thiourea gave maximum of 62% 
inhibition followed by catalase 48% and KI30%. The hydrogen peroxide so formed is 
probably converted to hydroxyl radical therefore, when Cu(II) is present in the reaction 
thiourea gave maximum inhibition followed by catalase. These results are in agreement 
with the previous report where a mechanism of photoexcitation of riboflavin alone and 
in the presence of metal ion was suggested (Ja2zar and Naseem, 1994). The involvement 
of copper in the lipid peroxidation reaction was fiirther confirmed by the use of 
bathocuproine. When bathocuproine was present in the reaction it inhibited lipid 
peroxidation by about 70% confirming that Cu(II) is converted to Cu(I) in the process, 
and the latter is an essential intermediate in the formation of hydroxyl radical. 
The polypeptide composition of RBC membrane obtained from fresh human RBC was 
analyzed by SDS-PAGE under various conditions. Loss of band corresponding to 
spectrin, after photo illumination in the presence of riboflavin alone and appearance of a 
smear at the top indicates aggregation. This may be due to the fact that when proteins are 
exposed to various damaging ROS, the hydrophobic region of the protein are exposed 
leading to the formation of noncovalent aggregates of different sizes (Grune et al., 
1995). Increasing the tune of riboflavin treatment resulted in extensive damage to 
membrane polypeptides. This is very obvious within 2 hours of incubation, where 
spectrin band was completely disappeared. The intensity of the rest of the bands also 
decreased significantly including band 3 which is the major intrinsic protein with an 
outer glycosylated domain. 
The membrane polypeptide pattern was different when Cu(II) was included in the 
reaction. Even after 10 minutesof incubation in fluorescent light, there was very clear 
aggregation above band 1, followed by very significant increase in the intensity of band 
7 after 40 minutes, indicating a cleavage pattern. The differences in polypeptide patterns 
of membranes treated with riboflavin alone and riboflavin-Cu(II) system indicate the 
involvement of different ROS in the two cases. Only certain polypeptides of RBC 
membrane were affected by riboflavin-Cu(II) treatment while with riboflavin ahnost 
every polypeptide band seemed to be effected. This may be due to the difference in flie 
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affinities of different proteins for Cu(II). There may be pockets in proteins wliere Cu(II) 
binds noncovalently generating a reaction center and when riboflavin is present in the 
vicinity of these regions it causes localized generation of hydroxyl radical. A similar 
situation exists in the generation of ROS at or near the drug-metal binding sites in DNA 
which is known to cause breaks in DNA (Aft et al, 1983 and Drayeretal, 1985). 
Damage caused by riboflavin-Cu(II) is restricted to some membrane polypeptides while 
others are spared as there may not be any putative Cu(II) binding sites in those proteins. 
This effect is in agreement with a previous observation (Jazzar and Naseem, 1994), 
where it was shown that riboflavin alone induced protein (BSA) aggregation while 
riboflavia-Cu(II) system caused degradation of protein. 
The above findings assume significance in view of the feet that photodynamic therapy is 
increasingly used with great success for the treatment ofa variety of tumors and cancer 
and attempts are being made to extend its use in the treatment of other clinical 
conditions (Webb et al., 1967, Bradly and Sharkey, 1977). Riboflavin is an important 
constituent of our daily diet. It is found in free and conjugated form in almost all 
biological tissues and fluids. The normal serum contains up to 8 |j.M loosely bound 
copper. Other biological fluids may also contain loosely boimd copper in the low 
micromolar range (Gutteidge, 1984, Rowley and Halliwell, 1983). Gutteridge defines 
loosely bound copper as those copper which is available for binding to a chelatmg agent 
like 1,10-phenanthroIine. It is possible that this loosely bound copper can be mobilized 
by riboflavin. Therefore, the risk of free radical mediated damage to tissue increases 
during phototherapy of various clinical disorders. However, further studies are necessary 
to evaluate the role of free radicals in cell damage, to understand their mechanism of 
action and conditions of their formation in vivo. 
ROS may be considered as the most important class ofmutagens contributing to aging 
and cancer (Ames et al., 1983). Such species when generated in the vicinity of a drug 
bound to DNA are known to cause strand scission (Aft et aL, 1983 and Drayeretal., 
1985). Repair enzymes that mediate the removal of such oxidative damage to DNA help 
counteract the potential cytotoxic, mutagenic and carcinogenic effects of these damages 
(Ames et al., 1993). In most cases hydroxyl radical has been suggested to be the 
predominant species responsible for damage. In the case of riboflavin, a ternary complex 
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of DNA-drug-Cu(II) is presumably formed (Naseem et al., 1988). A redox reaction 
involving riboflavin-Cu(Il) in the complex may then occur with the formation of DNA-
oxidized riboflavin-Cu(I) complex. During the process of conversion of Cu(II) to Cu(I), 
the molecular oxygen is reduced and variety of ROS are generated (Halliwell and 
Gutteridge, 1984, Ja2zar and Naseem, 1996). Since in the RBC sodium azide enhanced 
the damage caused by riboflavin-Cu(II) system, this combination was tested on DNA 
also. Calf thymus DNA was used as a target molecule and pea seed nuclease (prepared 
as described by Naseem and Hadi, 1987) was used as a probe to explore DNA damage. 
DNA, when exposed to photoilluminated riboflavin alone, showed partial hydrolysis 
which was enhanced when Cu(II) was included in the reaction. The presence of sodium 
azide in the reaction did not show any enhancement. Since the enhancing effect of 
sodium azide was significant when BSA was used as the target molecule in vitro system, 
we cannot rule out the possible generation ofazide radical through hydroxyl radical in 
vitro through the following reaction: 
W + OH- • Ns' + OH" 
The only possible reason for sodium azide not having any effect on DNA could be that 
azide radical generated is either too short lived to cause any damage or DNA is not the 
right substrate for azide radical. Thiols, phenols and other sulphur compoimds have been 
suggested to be the preferred targets for azide radical (Zhao etal., 1994, Froni and 
Willson, 1994, Alfasi and Schuler, 1985). These groups are present in proteins but 
absent in DNA, That is why the enhancing effect of sodium azide was seen on BSA and 
not on DNA. 
Riboflavin-aminophylline combination has been recommended for the effective 
treatment of jaundice in neonates (MeiseL et al. 1980). Aminophylline is the soluble 
form of theophylline. Both aminophylline and theophylline are widely used in the 
treatment of asthma (Kaneko et al., 1990), and have been shown to have anti-
inflammatory (Pauwels et al., 1985, Adachi et al., 1996, Mahomed etal., 1998) and 
immunomodulatory effects (Fames and Pauwels, 1991, Persson etal., 1991, Kidney et 
al., 1995, Kraft et al., 1996, Sullivan et al., 1994, Ward et al., 1993). The mechanism of 
this anti-inflammatory action has not, however, been clearly elucidated. Dent etal. 
103 
(1994) have shown that theophylline inhibits the respiratory burst of alveolar 
macrophages by elevation of cAMP, while others (Nielson et al, (1988) and DeTongi et 
a l , (1984)) have reported similar cAMP-dependent, negative effect of this agent on 
neutrophil activation. Theophylline at a therapeutic concentration increased the level of 
cAMP and caused a dose related inhibition ofsuperoxide radical generation by human 
neutrophils. Since neutrophil-derived reactive oxidants caused damage to the respiratory 
epithelium in a number of respiratory diseases, including asthma and chronic obstructive 
airways disease, this account, at least in part, for the beneficial anti-inflammatory role of 
the theophylline seen in these respiratory disorders (Mahomed et al., 1998). ROSdo 
play a role in the etiology of lung pathologies such as emphysema, adult respiratory 
distress syndrome and asthma (Ching et al., 1994). 
In the present work we have studied the effect of photoactivated riboflavm on RBC in 
the presence of aminophylline. Aminophylline caused the riboflavin-sensitized 
photohemolysis of human RBC in vitro, but had no effect in the absence of riboflavin 
even after prolonged incubation. The reaction was light mediated since no hemolysis 
occurred in light protected samples. Significantly, the hemolysis reaction did not require 
the presence of Cu(II). Based on the spectral studies of aminophylline and riboflavin as 
well as on previous findings (Naseem et aL, 1993, Jazzar and Naseem, 1996), we 
suggest that riboflavin upon photoexcitation generates the singlet state, which through 
intersystem conversion partially gives rise to triplet state. These singlet and triplet states 
of riboflavin, by transferring energy to molecular oxygen give rise to singlet and triplet 
oxygen species, which are very reactive and hence attack aminophylline. Aminophylline 
is converted to an unknown oxidized product and release hydroxyl radical, due to which 
there is decrease in the absorption at 270 nm. This hydroxyl radical damages RBC 
membrane, causing hemolysis. It also attacks riboflavin m the ground state and converts 
it to hydroxylated riboflavin leading to loss of conjugation and decrease in the 
absorption peak at 440 nm. The scheme given in Fig, 37, is supported by the observation 
that hemolysis of RBC is substantially inhibited by hydroxyl radical scavenger, while 
aminophylline peak of 270 nm is restored to a significant extent when sodium azide or 
KI are included m the reaction mixture. This reaction seems to be different from our 
previous study (Ali et al, 2000), where a metal ion like Cu(II) was essentially required. 
The major ROS generated in the process is probably hydroxyl radical as only thiourea 
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gave about 70% inhibition, while other scavengers like KI gave 22% inhibition. Similar 
effect of riboflavin-ammophylline combination is also seen in vitro when BSA is used as 
a target molecule and this effect was also inhibited by thiourea as in case of RBC. 
Theophylline is widely used for the treatment of idiopathic respiratory distress syndrome 
and apnea attacks in the newborns (Frati et al., 1997). Serum levelsof8-12 ng/ml 
theophylline are assumed to be therapeutically effective. However, in individuals in 
whom the theophylline plasma clearance is reduced for some reason, even a single 
mtravenous dose may result in increased serum theophylline level and potential toxicity. 
As theophylline is also distributed through breast milk, intravenous administration of 
theophylline to post pregnancy women may cause irritability, or other signs of toxicity 
in nursing infants, especially if the infant is undergoing phototherapy for treatment of 
neonatal jaundice. 
However the effect of aminophylline in combination with riboflavin in vivo remains to 
be examined. Therefore, fiarther studies are necessary to elucidate these points using an 
in vivo system. 
To get a more clear picture of the morphological changes that take place in RBC when 
treated with riboflavin alone, riboflavin-copper, riboflavin-Cu(II)-sodium azide or 
riboflavin-aminophylline combination, the scanning electron microscopy of RBC after 
various treatments was done. Normal RBC are known to have a biconcave shape. RBC, 
when exposed to lytic agents undergo a predictable series of changes in outline, passing 
through a "crenated disk" to "crenated sphere" then losing the crenation to form the 
"prolytic sphere" and finally undergoing hemolysis giving a red cell "ghost" (Lee et al., 
1998). Exposure of RBC to riboflavin under different conditions resulted in structural 
changes in RBC shape. RBC lost their biconcave shape and the cells adopted another 
shape called spherocyte (sphere). This spherocyte formation is known to occur usuaUy 
due to spectrin deficiency (Lee et al., 1998). This is in agreement with our result where 
we. have shown that incubation of membrane with photoiUuminated riboflavin alone 
caused degradation of spectrin. The presence of spherocyte is also associated with 
different disease states like anemia and jaundice (Lee et al., 1998). This structural 
change may result in partial r loss via very small holes in RBC membrane but without 
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any hemolysis as shown above. When Cu(II) was added to the reaction, the structural 
changes were more striking with the appearance ofsmall spikes ofvarying length and 
positioa These irregularly shaped RBC are called "acanthocytes", which are found to be 
associated with various diseases like liver disease and malabsorptive states (Williams et 
al., 1983). Acanthocytes are also the characteristic symptoms of abetalipoprotienemia 
(Barnard et al., 1989), an inherited disorder of lipid metaboHsm which results in 
abnormal incorporation of lipids into the RBC membrane. Although unusual hemolytic 
disease can be seen in abetalipoprotienemia. Dodge et al., (1963) have shown that 
hemolysis of acanthocytes occurs together vvith lipid peroxidatioa This is in agreement 
with our result where we have shown that the addition of copper resulted in the 
significant enhancement of lipid peroxidation. Acanthocytes formation is known to 
reflect an increase in the surfece area of the outer lipid layer in relation to the inner 
leaflet, presumably due to the increased sphingomyelin in the outer leaflet of bilayer 
(Zwaaletal, 1975). 
We have also discussed above that the addition of sodium azide resulted in the formation 
of azide radical. This azide radical seems to act differently from hydroxyl radical which 
is formed by riboflavin-Cu(II) systenx Azide radical caused a massive damage to the 
whole cell, leading to extensive hemolysis. This was clearly evident in the SEM, which 
showed completely damaged RBC. 
Incubation of RBC with riboflavin-aminophylline system results in the formation of a 
new morphology of RBC called "echinocytes". Echinocytes are RBC with equally 
spaced projections over the entire surface. These echinocytes are associated with 
different disease states like pyruvate kinase deficiency and uremia (Lee et al., 1998). 
The transformation of RBC from biconcave structure to echinocytes is known to occur 
due to action of various agents such as saponin, bile salts, soaps, ionic detergents, or 
lecithin (Weed and Chailly, 1972). Although, riboflavin-ammophylline combination acts 
via OH- like riboflavm-Cu(II) system, it resulted in the formation of different RBC 
morphology. The reason for the difference in their action is unclear. However, other 
morphologies of RBC like ellipocytes, stomatocytes and codocytes are also seen through 
out different treatment, but they are not very significant in number. 
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The data presented in this thesis strongly suggest that riboflavin upon photoexcitation 
generate ROS and can cause K"^  leakage to fresh human RBC. Addition of Cu(II) can 
induce hemolysis. The effect is significantly enhanced in the presence of sodium azide 
probably due to the generation of azide radical. Further studies are required to 
conclusively establish the formation of azide radical in our system. 
0 « 
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Riboflavin, a known vitamin of B group with a daily requirement of 2-3 mg is widely 
used in food products both as nutrient and as a coloring agent. Inside the system it works 
as a prosthetic group of several proteins and enzymes, where it is reversibly reduced by 
hydrogen atoms. Riboflavin when exposed to light gets excited and reacts via its triplet 
state with molecules like protonated substrate or molecular oxygen, generating ROS. 
Earlier reports have shown that photoexcited riboflavin generates superoxide radical and 
in the presence of a metal ion like Cu(n) caused fragmentation of DNA and proteins. 
In the present study we have examined the effect of photoilluminated riboflavin alone, 
riboflavin-Cu(II) system, riboflavin-Cu(Il)-sodium azide system and riboflavin-
aminophylline combination on human RBC. 
Fresh human RBC when irradiated with riboflavin in fluorescent light leads to K^ loss 
and lipid peroxidation. RBC membrane when was exposed to the above system lost its 
spectrin progressively with the appearance of smear at the top of the gel indicating 
cross-links. The electron micrograph has shown that RBC have lost their biconcave 
shape and "spherocytes" were formed. The formation of spherocytes is known to be 
associated with spectrin deficiency. 
When RBC were irradiated with riboflavin and Cu(II) in fluorescent light significant 
hemolysis was observed. There was enhancement of lipid peroxidation caused by 
riboflavin-Cu(II) system compared to riboflavin alone. When RBC membrane was 
exposed to riboflavin-Cu(II) system, degradation of ahnost all major bands was 
observed except band 7, whose intensity was increasing with increase in the time of 
incubation. Scanning electron micrograph of RBC treated with riboflavin-Cu(II) resulted 
in the appearance of spikes of different sizes on the surfece of RBC indicating the 
formation of "acanthocytes", which is usually prevalent in case of abetalipoprotienemia. 
The result of the experiment with different fi-ee radical scavengers strongly suggests the 
involvement of hydroxyl radical as the major ROS responsible for RBC structural 
changes and damage. 
Sodium azide a known scavenger of singlet oxygen is regularly used in free radical 
research. When sodium azide was used with riboflavin-Cu(II) system it enhanced 
(5i 
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hemolysis of RBC instead of inhibiting it. It also gave significant enhancement to lipid 
peroxidation and scanning electron microscopy has shown completely damaged RBC. 
Enhanced degradation was also observed when BSA was used as a target molecule. 
With scavengers pointing to hydroxyl radicals as the major ROS and the extent of 
damage significantly higher than riboflavin-Cu(II). The possibility of the generation of 
azide radical is strong, Azide radical is a known as one-electron rapid oxidant, which is 
difficult to detect. Experiment using DNA as the target molecule sodium azide did not 
show any enhancement compared to riboflavin-Cu(II). 
We, therefore, propose that the enhancii^ effect ofsodium azide is probably due to the 
combine effect of hydroxyl and azide radicals. 
Aminophylline a soluble form of theophylline is a routinely used medicine for various 
respiratory disorders especially asthma. Aminophylline when incubated with riboflavin 
in fluorescent Ught caused hemolysis of RBC. It was without any effect in the absence of 
riboflavin. Using different free radical scavengers, hydroxyl radical was indicated to be 
the major ROS involved in the reaction. The mechanism of generation of hydroxyl 
radical seems to be different from the riboflavin-Cu(II) system as it has no essential 
requirement for a metal ion. BSA in vitro when exposed to riboflavin-aminophylline 
combination was completely degraded and addition of thiourea resulted in significant 
inhibition. Scanning electron microscopy has shown clear formation of spikes of 
uniform length and size on the surfece of RBC. This form of RBC is known as 
"echinocytes". Echinocytes formation is associated with different disorders like low 
potassium, uremia and pyruvate kinase deficiency. The mechanism of RBC damage by 
riboflavin-aminophylline combmation is probably different from the one used by 
riboflavin-Cu(II) system. Using spectral studies we presume that riboflavin upon 
photoexcitation gave singlet oxygen which reacts with aminophylline forming hydroxyl 
radical and aminophylline in turn oxidized 
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Abstract 
The photodynamic action of riboflavin is generally considered to involve the generation of reactive oxygen species, whose production is 
enhanced when Cu(II) is present in the reaction. In the present study we report that photoactivated riboflavin causes K+ loss from fresh 
human red blood cells (RBC) in a time dependent manner. Addition of Cu(II) further enhances the K"*" loss and also leads to significant 
hemolysis. Riboflavin in a 2:1 stoichiometry with Cu(II) leads to maximum K+ loss and up to 45% hemolysis. Bathocuproine, a specific 
Cu(I)-sequestering agent, when present in the reaction, inhibits the hemolysis completely. Free radical scavengers like superoxide dismutase, 
potassium iodide and mannitol inhibited the hemolysis up to 55% or more. However, thiourea was the most effective scavenger showing 
90% inhibition. These results suggest that K+ leakage and hemolysis of human RBC are basically free radical mediated reactions. © 2000 
Elsevier Science B.V. All rights reserved. 
Keywords: Riboflavin; Copper; Oxygen radical; Red blood cell; Hemolysis 
1. Introduction 
In the presence of oxygen and visible light, riboflavin 
has been shown to be lethal to animal and human cells in 
culture and induce mutations in microorganisms [1,2]. We 
have previously shown that riboflavin in the presence of 
Cu(II) and light caused breakage of calf thymus DNA, 
supercoiled plasmid DNA [3] and degradation of bovine 
serum albumin [4]. Evidence from our laboratory and 
from other laboratories has shown that photoactivated 
riboflavin via its triplet excited state reacts with molecular 
oxygen and generates reactive oxygen species (ROS) 
[3,5,6^. These ROS are known to damage rat red blood 
ceU (RBC) membrane, induce hemolysis [7], damage rat 
lens [8], inactivate enzymes [9,10], increase protein cross-
Hnking [11,12], and destroy biUrubin [13], uric acid [14] 
and amino acids [15,16]. 
Oxidative modification of cellular constituents, includ-
ing lipids, proteins and nucleic acids, has been implicated 
in the etiology of different pathological conditions and in 
ageing [17]. The damage caused by oxidative stress is ex-
pected to be exacerbated if the antioxidant enzymes them-
selves are damaged and inactivated by such events [18]. 
Several lines of evidence suggest that the generation of 
* Corresponding author. Fax: +91 (571) 401089; 
E-mail: iyad74@mailcity.com 
ROS is intimately associated with the photodynamic effect 
of many drugs involved in cancer therapy [19]. While sin-
glet oxygen (Oj) is believed to be the major mediator of 
the reaction, oxygen species like the O'^ and OH" are also 
known to induce deleterious effects including lipid peroxi-
dation and membrane damage [20]. In fact, RBC have 
already been used as a target for O'^^ and hydrogen per-
oxide (H2O2) [21]. However, the results obtained have 
been less than optimally clear because RBC contain the 
protective enzymes superoxide dismutase, catalase and 
glutathione peroxidase that are free radical scavengers. 
Furthermore, both methemoglobin [22] and oxyhemoglo-
bin [23] can react with Oj" leading to precipitation of 
hemoglobin, thereby promoting hemolysis [24]. Several 
other hypotheses have been proposed to explain the mech-
anism of RBC hemolysis following oxidative stress in vivo 
and in vitro [25]. Hemoglobin appears to be the main site 
of damage when various oxidative drugs are used [26]. 
Under other oxidative conditions, the membrane appears 
to be the target of injury leading to hemolysis [27]. 
The administration of certain drugs, commonly desig-
nated as oxidants, stimulates the generation of ROS, 
which may overwhelm the cellular protective mechanism 
[28]. This is particularly likely when the defences of the 
RBC are already defective due to hereditary disorders [28]. 
The previous reports regarding the damaging eff'ect of 
photoactivated riboflavin on RBC require the presence of 
serum [7]. In this paper we show that photoactivated ribo-
0304-4165/00/$ - see front matter © 2000 Elsevier Science B.V. All rights reserved 
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flavin alone can cause K+ loss from human RBC and for 
the first time report that it leads to hemolysis if Cu(n) is 
also present in the reaction. 
2. Materials and methods 
Riboflavin, superoxide dismutase, (i-carotene and bath-
ocuproine were obtained from Sigma (St. Louis, MO, 
USA). Mannitol and cupric chloride were from British 
Drug Houses (BDH) (India). All other chemicals used 
were of the highest purity grade available commercially. 
2.1. Preparation of RBC 
RBC were prepared from fresh human blood by centri-
fugation at ISOOXg for 10 min at room temperature. The 
cells were washed three times with 5 vols, of isotonic NaCl 
solution and suspended in the desired buffer. 
2.2. Measurement of K* loss 
Packed RBC were suspended in 3 ml of 10 mM Tris-
HCl, pH 7.4, containing 0.15 M NaCl, varying amounts of 
riboflavin and Cu(II) to give 0.5% hematocrit. The reac-
tion mixtures were incubated at room temperature in 800 
lux of cool fluorescent light. 
After centrifugation at 1500x^ for 10 min the concen-
tration of K+ was measured in the supernatant using EEL 
flame photometry (Evans Electroselenium, Halsted, Essex, 
UK). For reference of 100% intracellular K+, a sample of 
RBC was hemolyzed in distilled water and K+ concentra-
tion determined in the supernatant after centrifugation as 
above. 
2.3. Measurement of hemolysis 
The percent hemolysis following incubation of RBC 
with riboflavin and Cu(II) was measured by reading the 
absorbance of the hemolysate at 415 nm as described by 
Yoshida et al. [29]. For reference, RBC were treated with 
distiUed water and hemolysate read at 415 nm to obtain 
100% hemolysis. All the experiments were carried out in 
triplicate and the mean values are reported. 
Wherever specified, varying amounts of free radical 
scavengers or bathocuproine were included in the reaction 
mixture (see legends for details). 
3. Results 
It is well estabUshed that riboflavin in the presence of 
UV or visible hght generates ROS [5,30]. Previous reports 
from this laboratory have shown that the presence of 
Cu(II) in the reaction results in the formation of more 
damaging species Uke 0\ and OH' via a modified Haber-
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Fig. 1. Effect of different riboflavin concentrations on intracellular K+ 
loss. Cells were incubated in 3 ml of buffer containing 10 mM Tris-HCl, 
pH 7.4, 0.15 M NaCl, 25-150 ^M riboflavin to give 0.5% hematocrit. 
The percentage of intracellular K+ loss was measured after 6 h of incu-
bation in fluorescent light (•) and in the dark (•). 
Weiss reaction [6]. These ROS are known to damage mac-
romolecules like DNA [3] and proteins [4] in vitro. As 
much work has already been reported on rat RBC [7] 
and other systems [8,14] it is, therefore, of interest to see 
the effect of these ROS on human RBC. 
The incubation of human RBC in fluorescent light with 
increasing concentrations of riboflavin for 6 h resulted in 
the progressive loss of intracellular K+ (Fig. 1). About 
50% K"*" loss was achieved at 50 |xM riboflavin. Further 
increase in the riboflavin concentrations did not result in 
any significant loss of intracellular K"*". 
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Fig. 2. Percent of K+ loss and hemolysis of RBC induced by different 
concentrations of Cu(n) in the presence of riboflavin. Cells were incu-
bated with 50 nM riboflavin and increasing concentrations of Cu(II). 
Hemolysis (•) and K+ loss (•) were monitored after 6 h of incubation. 
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The percent K+ loss and hemolysis of RBC by photo-
activated riboflavin with increasing concentrations of 
Cu(n) are shown in Fig. 2. There was an initial increase 
in extracellular K+ which stabihzed at around 50 |xM 
Cu(II). The maximum K+ loss was 80% in the presence 
of Cu(II) which is 30% more than when RBC were incu-
bated with riboflavin alone (Fig. 1). The presence of 
Cu(II) also induced significant hemolysis It was appreci-
able at 25 |J,M concentration of Cu(II). A maximum of 
45% hemolysis was, however, observed with 100 \iM 
Cu(II). Further increase in Cu(II) concentrations did not 
lead to any significant increase in hemolysis. Metals Uke 
Zn(II), Fe(III), Mg(II) and Mn(II) when used with ribo-
flavin instead of Cu(II) did not induce any significant he-
molysis under the same standard reaction conditions (data 
not shown). 
The percent K"*" loss and hemolysis in presence of 50 
\\M. riboflavin and 100 \iM Cu(II) were determined as a 
function of time (Fig. 3). After 1 h of incubation about 
18% of the intracellular K+ was lost into the medium 
without any significant hemolysis. Increasing the time of 
incubation to 2 h resulted in the release of 30% cellular K+ 
and 10% hemolysis, and after 6 h 80%) of the intracellular 
K"*" was lost with 45%) hemolysis. In the absence of Cu(II), 
RBC did not exhibit any hemolysis even after prolonged 
incubation. In light-protected control samples, loss of cel-
lular K"*" or hemolysis was not observed in the presence of 
both riboflavin and Cu(II) (data not shown), suggesting 
that the reaction is light mediated. 
In order to investigate whether Cu(I) played a role in 
hemolysis, the Cu(I)-sequestering agent bathocuproine was 
included in the reaction containing riboflavin and Cu(II). 
Complete inhibition of hemolysis was achieved at 25 |iM 
bathocuproine (Fig. 4) showing a Cu(I): bathocuproine 
stoichiometry of 4:1. 
Bathocuproine / n ]V1 ) 
Fig 4 Effect of bathocuproine on the hemolysis of RBC induced by ri-
boflavin and Cu(II) Cells were incubated with 50 |iM riboflavin, 100 
HM Cu(II) and varying concentrations (10-50 |iM) of bathocuproine 
After 6 h incubation in fluorescent light, hemolysis was determined and 
compared with controls lacking bathocuproine 
Several free radical scavengers were included in the re-
action to identify the major ROS participating m the RBC 
hemolysis. As shown in Fig. 5, potassium iodide, a scav-
enger of triplet oxygen, gave 60%o inhibition of RBC he-
molysis. Superoxide dismutase (SOD), the scavenger of 
Oj", showed 52%) inhibition, while catalase, the scavenger 
of H2O2, and p-carotene, the scavenger of both 0\ and 
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Fig 3 Effect of increasing time of incubation on the hemolysis and in-
tracellular K"*" loss from human RBC Cells were incubated with 50 nM 
riboflavin and 100 (j.M Cu(II) for different time intervals D, K loss, 
O, K loss (without Cu(II)), • , hemolysis, • , hemolysis (without Cu(II)) 
Fig 5 Inhibition of RBC hemolysis by various free radical scavengers 
Cells were incubated with 50 (iM riboflavin and 100 |iM Cu(II) and 0 I 
mM of either manmtol, thiourea, potassium iodide, p-carotene or 20 [ig/ 
ml of SOD or catalase The incubation was for 6 h in fluorescent light 
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nitric oxide (NO'), did not show any inhibition. Mannitol 
and thiourea, both scavengers of OH", showed 63% and 
93% inhibition respectively, indicating OH' as the major 
ROS involved in the reaction. 
4. Discussion 
Riboflavin or vitamin B2 is the prosthetic group of sev-
eral proteins and enzymes which is reversibly reduced by 
hydrogen atoms. When exposed to hght, riboflavin ab-
sorbs energy and reacts via its triplet excited state with 
other molecules such as protonated substrates or molecu-
lar oxygen generating ROS [31]. These ROS are well 
known for their damaging effect on several biological mol-
ecules [3,4]. The present observations illustrate the effect of 
photoactivated riboflavin on intracellular K+ loss and he-
molysis of human RBC. In the presence of riboflavin and 
visible light, significant loss of intracellular K+ is observed 
(Fig. 1) which is probably due to an alteration in the 
permeability of the RBC membrane. In addition, this re-
sult also shows that the photosensitized riboflavin ren-
dered the cell membrane permeable to K+, but not to 
large molecules Uke hemoglobin as no hemolysis was ob-
served under these conditions. 
Riboflavin in the presence of Cu(II) and visible hght has 
been shown to cause breakage of calf thymus DNA [3] 
and fragmentation of proteins [4]; therefore, the effect of 
riboflavin on human RBC was also studied in the presence 
of Cu(II) (Fig. 2). The hemolysis of RBC started after a 
lag of 60 min, when intracellular K""" loss was already 18% 
and increased progressively up to 6 h with the maximum 
being 45%. However, after 6 h the maximum K"*" loss was 
80%). No further hemolysis was observed up to 10 h of 
incubation in light (data not shown). 
The eff'ect of Cu(II) on RBC leading to hemolysis may 
arise from the fact that Cu(II) interacts with photoacti-
vated riboflavin to provide a long-hved excited species. 
Direct charge transfer from excited riboflavin can then 
generate the singlet and triplet oxygen [6]. Other ROS 
such as OH' or hydroxide ion (0H~) are also generated 
in the reaction via a modified Haber-Weiss reaction when 
Cu(II), water and molecular oxygen are present. In our 
previous study [3] we found that the addition of Cu(II) 
to riboflavin reaction inhibited the photodegradation of 
riboflavin and in this process Cu(II) is reduced to Cu(I). 
To see if Cu(I) is also involved in RBC hemolysis reaction, 
riboflavin-Cu(II) mediated hemolysis was carried out in 
the presence of bathocuproine, a known Cu(I)-sequester-
ing agent. Complete inhibition was achieved at 25 |J,M 
bathocuproine (Fig. 4), confirming once again that 
Cu(II) is reduced to Cu(I) and the latter is an essential 
intermediate in the reaction. 
Scavengers of various ROS were also included in the 
reaction (Fig. 5). The results of this experiment strongly 
suggest OH' as the major ROS involved in the RBC dam-
aging reaction. This observation is based on the fact that 
thiourea substantially and D-mannitol to a lesser extent 
prevented hemolysis. On the other hand, potassium iodide 
gave 63% inhibition, suggesting that singlet and triplet 
excited states of oxygen also play a significant role in 
hemolysis. This is in agreement with our previous report 
on a bacterial system [6] where we have proposed a scheme 
for photodegradation of riboflavin in which the presence 
of Cu(II) generates Oj and OH" from Oj" via a modified 
Haber-Weiss reaction. 
The above findings assume significance in view of the 
fact that photodynamic therapy is increasingly used with 
great success for the treatment of a variety of tumors and 
cancer and attempts are being made to extend its use in 
the treatment of other clinical conditions [1,2]. Riboflavin 
is an important constituent of our daily diet. It is found in 
free and conjugated form in almost all biological tissues 
and fluids. The normal serum contains up to 8 |iM loosely 
bound copper. Other biological fluids may also contain 
loosely bound copper in the low micromolar range 
[32,33]. Gutteridge defines loosely bound copper as that 
copper which is available for binding to a chelating agent 
like 1,10-phenanthrohne. It is possible that this loosely 
bound copper can be mobilized by riboflavin. Therefore, 
the risk of free radical mediated dama,ge to tissue increases 
during phototherapy of various clinical disorders. How-
ever, further studies are necessary to evaluate the role of 
free radicals in cell damage, to understand their mecha-
nism of action and conditions of their formation in vivo. 
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